Kowsar Publishing Company

  • Register
    All fields are required(*) .

Professor Seyed-Moayed Alavian

 

Professor Seyed-Moayed Alavian MD,

Professor of Gastroenterology and Hepatology

Head of Research Center for Gastroenterology and Liver Disease,

 

Founder and President of Global Hepatitis Network,


 

Professor Seyed-Moayed Alavian received his Medical Doctorate with a specialty in Internal Medicine, from Tehran University of Medical Sciences. He began his work as a fellow of the Digestive Disease Research Center (DDRC) at Shariati Hospital from 1992 until 1994. He was ranked second in the country in the subspecialty board’s exam.

Professor Alavian established the first hepatitis clinic at the Iranian Blood Transfusion Service in Tehran in 1995; that center has registered 7000 cases of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection since then. He founded the Iranian Charity for Liver Support in 1995 in Tehran. He is a member of the editorial board of several creditable local and international journals. He has been the associate editor of the Journal of Clinical Virology for 6 years. He has been an adviser and consultant on national program projects for the control of hepatitis in Iran. He is a member of the National Committee for Hepatitis in the Iranian Ministry of Health and Medical Education since 1995. He has been given several grants by national and international research centers for research on viral hepatitis. Professor Alavian is an experienced researcher and hepatologist who has been actively involved in various national multicenter clinical trials and basic scientific projects related to viral hepatitis over the past 19 years.

He has authored/co-authored over 390 articles in local and international journals, including 280 articles indexed in ISI, 210 articles indexed in Medline, and 55 articles indexed in Persian Journals and more than 850 citations to published articles as well as 42 books and booklets for physicians and patients. He has been the principal investigator in numerous clinical trials related to the management and treatment of hepatitis C and B patients. His main interests are health policy, the epidemiological aspects of viral hepatitis and methods of integrating new protocols for the control of these infections. He is also interested in clinical trials of emerging medications for HBV and HCV, and treatment of viral hepatitis in special diseases including thalassemia and hemophilia.


 

Professor of Gastroenterology and Hepatology,

Founder and Director of Iran Hepatitis Network (www.hep.ir),

Editor in Chief of Hepatitis Monthly,

 


Links: Publications in PubMed 

 


List of Publications:

  • 1: Rezaee-Zavareh MS, Salamati P, Alavian SM. Post-sanctions era in Iran: opportunity for science and publication. Lancet. 2016 Jul 2;388(10039):29. doi: 10.1016/S0140-6736(16)30898-4. PubMed PMID: 27397790.
  • 2: Poortahmasebi V, Emami Aleagha MS, Amiri M, Qorbani M, Farahmand M, Asayesh H, Alavian SM. Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C. Med J Islam Repub Iran. 2016 Feb 7;30:322. eCollection 2016. PubMed PMID: 27390692; PubMed Central PMCID: PMC4898852.
  • 3: Sadeghi A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, Poortahmasebi V, Poorebrahim M, Mohraz M, Hajabdolbaghi M, Rasoolinejad M, Abbasian L, Jafari R, Fakhari Z, Norouzi M, Ebrahimian A, Geravand B, Alavian SM, Jazayeri SM. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg. J Med Virol. 2016 Jul 6. doi: 10.1002/jmv.24623. [Epub ahead of print] PubMed PMID: 27381922.
  • 4: Sepehri Z, Kiani Z, Alavian SM, Arababadi MK, Kennedy D. The link between TLR7 signaling and hepatitis B virus infection. Life Sci. 2016 Jun 29. pii: S0024-3205(16)30382-4. doi: 10.1016/j.lfs.2016.06.026. [Epub ahead of print] Review. PubMed PMID: 27373425.
  • 5: Alavian SM, Imanieh MH, Imanieh MH. Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections. Hepat Mon. 2016 May 3;16(5):e34790. doi: 10.5812/hepatmon.34790. eCollection 2016 May. PubMed PMID: 27330536; PubMed Central PMCID: PMC4912694.
  • 6: Bokharaei-Salim F, Salehi-Vaziri M, Sadeghi F, Esghaei M, Monavari SH, Alavian SM, Fakhim S, Keyvani H. The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients. Hepat Mon. 2016 Apr 23;16(5):e35597. doi: 10.5812/hepatmon.35597. eCollection 2016 May. PubMed PMID: 27313635; PubMed Central PMCID: PMC4908614.
  • 7: Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016 Apr 18;16(4):e37089. doi: 10.5812/hepatmon.37089. eCollection 2016 Apr. Review. PubMed PMID: 27275164; PubMed Central PMCID: PMC4893415.
  • 8: Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepat Mon. 2016 Apr 19;16(4):e35558. doi: 10.5812/hepatmon.35558. eCollection 2016 Apr. Review. PubMed PMID: 27274353; PubMed Central PMCID: PMC4894080.
  • 9: Tavakolpour S, Alavian SM, Sali S. Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened. Hepat Mon. 2016 Mar 26;16(4):e35810. doi: 10.5812/hepatmon.35810. eCollection 2016 Apr. Review. PubMed PMID: 27257429; PubMed Central PMCID: PMC4887960.
  • 10: Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon. 2016 Apr 26;16(4):e35577. doi: 10.5812/hepatmon.35577. eCollection 2016 Apr. Review. PubMed PMID: 27257428; PubMed Central PMCID: PMC4888501.
  • 11: Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepat Mon. 2016 Mar 6;16(4):e32636. doi: 10.5812/hepatmon.32636. eCollection 2016 Apr. Review. PubMed PMID: 27257423; PubMed Central PMCID: PMC4887963.
  • 12: Gholami M, Ravanshad M, Alavian SM, Baesi K, Moallemi S. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients]. Mol Biol (Mosk). 2016 Mar-Apr;50(2):279-83. doi: 10.7868/S0026898416020075. Russian. PubMed PMID: 27239848.
  • 13: Rezaee-Zavareh MS, Sa'adat SH, Alavian SM. Hepatitis Monthly, an International Journal in the Field of Hepatology. Hepat Mon. 2016 Mar 12;16(3):e37015. doi: 10.5812/hepatmon.37015. eCollection 2016 Mar. PubMed PMID: 27226805; PubMed Central PMCID: PMC4875567.
  • 14: Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon. 2016 Mar 26;16(3):e35664. doi: 10.5812/hepatmon.35664. eCollection 2016 Mar. Review. PubMed PMID: 27226804; PubMed Central PMCID: PMC4875562.
  • 15: Alavian SM, Haghbin H. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Hepat Mon. 2016 Mar 6;16(3):e35106. doi: 10.5812/hepatmon.35106. eCollection 2016 Mar. Review. PubMed PMID: 27226803; PubMed Central PMCID: PMC4875504.
  • 16: Ansari-Moghaddam A, Ansari H, Khosravi S, Sanei-Moghaddam E, Mohammadi M, Alavian SM, Poustchi H. The Prevalence of Hepatitis B Virus Among Municipal Solid Waste Workers: Necessity for Immunization of At-Risk Groups. Hepat Mon. 2016 Mar 6;16(3):e30887. doi: 10.5812/hepatmon.30887. eCollection 2016 Mar. PubMed PMID: 27226797; PubMed Central PMCID: PMC4875503.
  • 17: Aminizadeh E, Alavian SM, Akbari Sari A, Ebrahimi Daryani N, Behnava B. Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials. Hepat Mon. 2016 Mar 6;16(3):e28537. doi: 10.5812/hepatmon.28537. eCollection 2016 Mar. Review. PubMed PMID: 27226796; PubMed Central PMCID: PMC4876663.
  • 18: Poortahmasebi V, Poorebrahim M, Najafi S, Jazayeri SM, Alavian SM, Arab SS, Ghavami S, Alavian SE, Rezaei Moghadam A, Amiri M. How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study. Hepat Mon. 2016 Feb 20;16(2):e36005. doi: 10.5812/hepatmon.36005. eCollection 2016 Feb. PubMed PMID: 27148389; PubMed Central PMCID: PMC4852094.
  • 19: Pouryasin M, Keshvari M, Sharafi H, Alavian SM, Behnava B, Alavian SE, Pouryasin A. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C. Hepat Mon. 2016 Feb 20;16(2):e35278. doi: 10.5812/hepatmon.35278. eCollection 2016 Feb. PubMed PMID: 27148387; PubMed Central PMCID: PMC4851836.
  • 20: Khosravi MH, Alavian SM. Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function? J Korean Med Sci. 2016 May;31(5):824. doi: 10.3346/jkms.2016.31.5.824. Epub 2016 Mar 22. PubMed PMID: 27134509; PubMed Central PMCID: PMC4835614.
  • 21: Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Hepat Mon. 2016 Jan 23;16(1):e34897. doi: 10.5812/hepatmon.34897. eCollection 2016 Jan. PubMed PMID: 27110262; PubMed Central PMCID: PMC4834197.
  • 22: Behnava B, Sharafi H, Keshvari M, Pouryasin A, Mehrnoush L, Salimi S, Karimi Elizee P, Ghazimoghaddam M, Alavian SM. The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C. Hepat Mon. 2016 Jan 23;16(1):e32703. doi: 10.5812/hepatmon.32703. eCollection 2016 Jan. PubMed PMID: 27110259; PubMed Central PMCID: PMC4834189.
  • 23: Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, Keshvari M. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon. 2016 Jan 23;16(1):e32215. doi: 10.5812/hepatmon.32215. eCollection 2016 Jan. PubMed PMID: 27110256; PubMed Central PMCID: PMC4834187.
  • 24: Soozande M, Arabalibeik H, Alavian SM. Reduced Imaging Rate in Liver Elastometery Using Shear Wave Interference Patterns. Stud Health Technol Inform. 2016;220:390-5. PubMed PMID: 27046611.
  • 25: Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015 Dec 29;15(12):e35238. doi: 10.5812/hepatmon.35238. eCollection 2015 Dec. Review. PubMed PMID: 26977171; PubMed Central PMCID: PMC4779254.
  • 26: Bagheri Lankarani K, Homayon K, Motevalli D, Heidari ST, Alavian SM, Malek-Hosseini SA. Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran. Hepat Mon. 2015 Dec 27;15(12):e26407. doi: 10.5812/hepatmon.26407. eCollection 2015 Dec. PubMed PMID: 26977162; PubMed Central PMCID: PMC4779252.
  • 27: Parivar K, Malekvand Fard F, Bayat M, Alavian SM, Motavaf M. Evaluation of Iron Oxide Nanoparticles Toxicity on Liver Cells of BALB/c Rats. Iran Red Crescent Med J. 2016 Jan 30;18(1):e28939. doi: 10.5812/ircmj.28939. eCollection 2016 Jan. PubMed PMID: 26889399; PubMed Central PMCID: PMC4753026.
  • 28: Rezaee Zavareh MS, Alavian SM. Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies. Hepat Mon. 2015 Nov 28;15(11):e33462. doi: 10.5812/hepatmon.33462. eCollection 2015 Nov. PubMed PMID: 26834794; PubMed Central PMCID: PMC4717287.
  • 29: Rezaee-Zavareh MS, Karimi-Sari H, Alavian SM. Iran, sanctions, and research collaborations. Lancet. 2016 Jan 2;387(10013):28-9. doi: 10.1016/S0140-6736(15)01295-7. PubMed PMID: 26766342.
  • 30: Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Hossein Khosravi M, Ajudani R, Dolatimehr F, Ramezani-Binabaj M, Miri SM, Alavian SM. Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J. 2015 Nov 29;17(11):e34181. doi: 10.5812/ircmj.34181. eCollection 2015 Nov. Review. PubMed PMID: 26734487; PubMed Central PMCID: PMC4698335.
  • 31: Yeganeh B, Rezaei Moghadam A, Alizadeh J, Wiechec E, Alavian SM, Hashemi M, Geramizadeh B, Samali A, Bagheri Lankarani K, Post M, Peymani P, Coombs KM, Ghavami S. Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response. World J Gastroenterol. 2015 Dec 21;21(47):13225-39. doi: 10.3748/wjg.v21.i47.13225. PubMed PMID: 26715805; PubMed Central PMCID: PMC4679754.
  • 32: Ramezani F, Alavian SM, Sadeghi A, Khedive A, Ghalichi L, Norouzi M, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Keyvani H, Kalantari E, Saberfiroozi M, Rezaee R, Daram M, Mahabadi M, Goodarzi Z, Poortahmasebi V, Geravand B, Khamseh A, Mahmoodi M, Jazayeri SM. Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces. Iran J Microbiol. 2015 Aug;7(4):214-20. PubMed PMID: 26697161; PubMed Central PMCID: PMC4685166.
  • 33: Shoghli A, Nabavi SM, Alavian SM, Kolifarhood G, Goya MM, Namazi R, Fallahnezhad M, Mohajeri M, Mousavinasab N, Zanjani RS, Saeini MR, Jalilvand A. Hepatitis B surface antigen prevalence in pregnant women: A cross-sectional survey in Iran. Int J Prev Med. 2014 Dec;5(Suppl 3):S213-8. PubMed PMID: 26622992; PubMed Central PMCID: PMC4635415.
  • 34: Sadeghi A, Yahyapour Y, Poortahmasebi V, Shahmoradi S, Roggendorf M, Karimzadeh H, Alavian SM, Jazayeri SM. Clearance of HBV DNA in immunized children born to HBsAg-positive mothers, years after being diagnosed with occult HBV infection. J Viral Hepat. 2016 Apr;23(4):282-5. doi: 10.1111/jvh.12490. Epub 2015 Nov 24. PubMed PMID: 26598112.
  • 35: Jazayeri SM, Sharafi H, Alavian SM. Appropriate Genotyping of Hepatitis B Virus in Iran. Jundishapur J Microbiol. 2015 Oct 17;8(10):e23529. doi: 10.5812/jjm.23529. eCollection 2015 Oct. PubMed PMID: 26587209; PubMed Central PMCID: PMC4644268.
  • 36: Shamsoddini A, Sobhani V, Ghamar Chehreh ME, Alavian SM, Zaree A. Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease. Hepat Mon. 2015 Oct 10;15(10):e31434. doi: 10.5812/hepatmon.31434. eCollection 2015 Oct. PubMed PMID: 26587039; PubMed Central PMCID: PMC4644631.
  • 37: Soleimanpour H, Safari S, Rahmani F, Nejabatian A, Alavian SM. Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article. Hepat Mon. 2015 Oct 10;15(10):e27063. doi: 10.5812/hepatmon.27063. eCollection 2015 Oct. Review. PubMed PMID: 26587034; PubMed Central PMCID: PMC4644574.
  • 38: Mohammadi A, Tajik N, Shah-Hosseini A, Alavian SM, Sharifi Z, Jarahi L. FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection. Hepat Mon. 2015 Oct 10;15(10):e26490. doi: 10.5812/hepatmon.26490. eCollection 2015 Oct. PubMed PMID: 26587033; PubMed Central PMCID: PMC4644599.
  • 39: Lankarani KB, Alavian SM. Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis. Gastroenterology. 2015 Dec;149(7):1987-8. doi: 10.1053/j.gastro.2015.09.044. Epub 2015 Oct 26. PubMed PMID: 26515490.
  • 40: Alfaleh FZ, Nugrahini N, Matičič M, Tolmane I, Alzaabi M, Hajarizadeh B, Valantinas J, Kim DY, Hunyady B, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alavian SM, Alawadhi S, Al-Dabal L, Aldins P, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Goldis A, Gottfredsson M, Gregorcic S, Gunter J, Hamid S, Han KH, Hasan I, Hashim A, Horvath G, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim YS, Koutoubi Z, Lesmana LA, Liakina V, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sharara AI, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Ud Din M, Umar M, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Blach S. Strategies to manage hepatitis C virus infection disease burden - volume 3. J Viral Hepat. 2015 Dec;22 Suppl 4:42-65. doi: 10.1111/jvh.12474. PubMed PMID: 26513447.
  • 41: Sibley A, Han KH, Abourached A, Lesmana LA, Makara M, Jafri W, Salupere R, Assiri AM, Goldis A, Abaalkhail F, Abbas Z, Abdou A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alavian SM, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Gottfredsson M, Gregorcic S, Gunter J, Hajarizadeh B, Hamid S, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jeruma A, Jonasson JG, Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Liakina V, Lim YS, Löve A, Maimets M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Sharara AI, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Schmelzer JD. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3. J Viral Hepat. 2015 Dec;22 Suppl 4:21-41. doi: 10.1111/jvh.12476. PubMed PMID: 26513446.
  • 42: Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, Gheorghe L, El Hassan ES, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Goldis A, Gottfredsson M, Gregorcic S, Hajarizadeh B, Han KH, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Lesmana LA, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Gunter J. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3. J Viral Hepat. 2015 Dec;22 Suppl 4:4-20. doi: 10.1111/jvh.12475. PubMed PMID: 26513445.
  • 43: Tajik Z, Keyvani H, Bokharaei-Salim F, Zolfaghari MR, Fakhim S, Keshvari M, Alavian SM. Detection of Hepatitis B Virus Covalently Closed Circular DNA in the Plasma of Iranian HBeAg-Negative Patients With Chronic Hepatitis B. Hepat Mon. 2015 Sep 29;15(9):e30790. doi: 10.5812/hepatmon.30790. eCollection 2015 Sep. PubMed PMID: 26504471; PubMed Central PMCID: PMC4612772.
  • 44: Pouresmaeeli M, Alavian SM, Keshvari M, Salimi S, Mehrnoush L. Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C. Hepat Mon. 2015 Sep 29;15(9):e30780. doi: 10.5812/hepatmon.30780. eCollection 2015 Sep. PubMed PMID: 26504470; PubMed Central PMCID: PMC4612773.
  • 45: Alavian SM, Ataei B, Ebrahimi A, Pirhaji O, Azad R, Olya B, Ataei AM. Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors. Hepat Mon. 2015 Sep 8;15(9):e23633. doi: 10.5812/hepatmon.23633. eCollection 2015 Sep. PubMed PMID: 26500681; PubMed Central PMCID: PMC4612687.
  • 46: Shirvani-Dastgerdi E, Pourkarim MR, Herbers U, Amini-Bavil-Olyaee S, Yagmur E, Alavian SM, Trautwein C, Tacke F. Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro. Clin Microbiol Infect. 2016 Jan;22(1):98.e1-6. doi: 10.1016/j.cmi.2015.09.020. Epub 2015 Oct 30. PubMed PMID: 26433026.
  • 47: Ghaleh Baghi S, Alavian SM, Mehrnoush L, Salimi S. Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection. Hepat Mon. 2015 Jul 22;15(7):e28287. doi: 10.5812/hepatmon.28287v2. eCollection 2015 Jul. PubMed PMID: 26300930; PubMed Central PMCID: PMC4539734.
  • 48: Ahmad Akhoundi MS, Momeni N, Norouzi M, Ghalichi L, Shamshiri AR, Alavian SM, Poortahmasebi V, Jazayeri SM. Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey. Int J Occup Med Environ Health. 2015;28(3):593-602. doi: 10.13075/ijomeh.1896.00324. PubMed PMID: 26190734.
  • 49: Mehrnoush L, Alavian SM, Sharafi H, Behnava B, Salimi S, Keshvari M. High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study. Pediatr Hematol Oncol. 2015;32(6):399-405. doi: 10.3109/08880018.2015.1022915. Epub 2015 Jun 18. PubMed PMID: 26086432.
  • 50: Akbari Sari A, Kazemi Karyani A, Alavian SM, Arab M, Rostami Gholmohamadi F, Rezaei S. The Economic Burden of Liver Cirrhosis in Iran: a Cost of Illness Study. Iran J Public Health. 2015 Apr;44(4):512-21. PubMed PMID: 26056670; PubMed Central PMCID: PMC4441964.
  • 51: Bakhshizadeh F, Hekmat S, Keshvari M, Alavian SM, Mostafavi E, Keivani H, Doosti-Irani A, Motevalli F, Behnava B. Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B. Hepat Mon. 2015 May 23;15(5):e25749. doi: 10.5812/hepatmon.15(5)2015.25749. eCollection 2015 May. PubMed PMID: 26045705; PubMed Central PMCID: PMC4451271.
  • 52: Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study. Hepat Mon. 2015 Apr 25;15(5):e23618. doi: 10.5812/hepatmon.15(04)2015.23618. eCollection 2015 May. Review. PubMed PMID: 26045701; PubMed Central PMCID: PMC4451270.
  • 53: Keshavarz K, Kebriaeezadeh A, Alavian SM, Akbari Sari A, Abedin Dorkoosh F, Keshvari M, Malekhosseini SA, Nikeghbalian S, Nikfar S. Economic burden of hepatitis B virus-related diseases: evidence from iran. Hepat Mon. 2015 Apr 25;15(4):e25854. doi: 10.5812/hepatmon.15(4)2015.25854. eCollection 2015 Apr. PubMed PMID: 25977694; PubMed Central PMCID: PMC4427913.
  • 54: Keshvari M, Alavian SM, Sharafi H. Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients. Jundishapur J Microbiol. 2015 Jan 14;8(3):e21444. doi: 10.5812/jjm.21444. eCollection 2015 Mar. Erratum in: Jundishapur J Microbiol. 2015 Dec;8(12):e31014. PubMed PMID: 25973160; PubMed Central PMCID: PMC4426187.
  • 55: Samimi-Rad K, Sadeghi F, Amirzargar A, Eshraghian MR, Alavian SM, Rahimnia R. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran. J Med Virol. 2015 Sep;87(9):1565-72. doi: 10.1002/jmv.24211. Epub 2015 May 12. PubMed PMID: 25970464.
  • 56: Alavian SM. Hepatitis C genotypes distribution in intravenous drug users in tehran. Jundishapur J Microbiol. 2015 Jan 14;8(3):e17134. doi: 10.5812/jjm.17134. eCollection 2015 Mar. PubMed PMID: 25969703; PubMed Central PMCID: PMC4419385.
  • 57: Keshvari M, Sharafi H, Alavian SM, Mehrabadi H, Zolfaghari S. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus Apher Sci. 2015 Aug;53(1):38-47. doi: 10.1016/j.transci.2015.03.003. Epub 2015 Mar 12. PubMed PMID: 25892591.
  • 58: Sali S, Sharafi H, Alavian SH, Alavian SM, Etesam F, Salimi S, Merza MA, Keshvari M. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state? Diagn Microbiol Infect Dis. 2015 Jun;82(2):114-9. doi: 10.1016/j.diagmicrobio.2015.02.005. Epub 2015 Feb 20. PubMed PMID: 25863529.
  • 59: Dadmanesh M, Ranjbar MM, Alavian SM, Ghorban K. Sequencing and Phylogenetic Study of Partial NS3 Gene of Iranian GB Virus C/Hepatitis G Virus (HGV) Originated From Hemodialysis Patients in Tehran. Hepat Mon. 2015 Mar 5;15(3):e24173. doi: 10.5812/hepatmon.24173. eCollection 2015 Mar. PubMed PMID: 25838830; PubMed Central PMCID: PMC4379489.
  • 60: Saffari M, Alavian SM, Naderi MK, Pakpour AH, Al Zaben F, Koenig HG. Cross-Cultural Adaptation and Psychometric Assessment of the Liver Disease Symptom Index 2.0 to Measure Health-Related Quality of Life Among Iranian Patients With Chronic Hepatitis B. J Transcult Nurs. 2015 Mar 23. pii: 1043659615577698. [Epub ahead of print] PubMed PMID: 25801763.
  • 61: Soleimanpour H, Safari S, Rahmani F, Jafari Rouhi A, Alavian SM. Intravenous hypnotic regimens in patients with liver disease; a review article. Anesth Pain Med. 2015 Feb 24;5(1):e23923. doi: 10.5812/aapm.23923. eCollection 2015 Feb. Review. PubMed PMID: 25793176; PubMed Central PMCID: PMC4352868.
  • 62: Alavian SM. Liver biopsy versus non-invasive tests in determining liver disease status. Iran J Radiol. 2015 Jan 18;12(1):e17078. doi: 10.5812/iranjradiol.17078. eCollection 2015 Jan. PubMed PMID: 25793088; PubMed Central PMCID: PMC4349103.
  • 63: Soleimanpour H, Safari S, Rahmani F, Ameli H, Alavian SM. The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article. Anesth Pain Med. 2015 Jan 7;5(1):e23409. doi: 10.5812/aapm.23409. eCollection 2015 Feb. Review. PubMed PMID: 25789242; PubMed Central PMCID: PMC4350156.
  • 64: Behzadi P, Ranjbar R, Alavian SM. Nucleic Acid-based approaches for detection of viral hepatitis. Jundishapur J Microbiol. 2014 Dec 10;8(1):e17449. doi: 10.5812/jjm.17449. eCollection 2015 Jan. Review. PubMed PMID: 25789132; PubMed Central PMCID: PMC4350052.
  • 65: Ardalan G, Alavian SM. School nutrition program; prevention of obesity and Fatty liver in children. Iran J Pediatr. 2014 Aug;24(4):337-8. Epub 2014 Jun 29. PubMed PMID: 25755851; PubMed Central PMCID: PMC4339553.
  • 66: Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1. Hepat Mon. 2015 Jan 1;15(1):e24955. doi: 10.5812/hepatmon.24955. eCollection 2015 Jan. PubMed PMID: 25741374; PubMed Central PMCID: PMC4330713.
  • 67: Sandoughdaran S, Alavian SM, Sharafi H, Behnava B, Salimi S, Mehrnoush L, Karimi Elizee P, Keshvari M. Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy. Hepat Mon. 2015 Jan 13;15(1):e23564. doi: 10.5812/hepatmon.23564. eCollection 2015 Jan. PubMed PMID: 25741371; PubMed Central PMCID: PMC4344648.
  • 68: Momeni N, Ahmad Akhoundi MS, Alavian SM, Shamshiri AR, Norouzi M, Mahboobi N, Moosavi N, Jazayeri SM. HBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measures. Hepat Mon. 2014 Dec 27;15(1):e20014. doi: 10.5812/hepatmon.20014. eCollection 2015 Jan. PubMed PMID: 25741367; PubMed Central PMCID: PMC4344650.
  • 69: Mahboobi N, Alavian SM. Oral conditions might cause severe outcomes in patients with viral hepatitis infection. Hepat Mon. 2014 Dec 25;14(12):e25866. doi: 10.5812/hepatmon.25866. eCollection 2014 Dec. PubMed PMID: 25737733; PubMed Central PMCID: PMC4329236.
  • 70: Firouznia K, Ghanaati H, Alavian SM, Azadeh P, Nasiri Toosi M, Haj Mirzaian A, Najafi S, Shakiba M, Jalali AH. Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma. Hepat Mon. 2014 Dec 28;14(12):e25792. doi: 10.5812/hepatmon.25792. eCollection 2014 Dec. PubMed PMID: 25737732; PubMed Central PMCID: PMC4329238.
  • 71: Firouznia K, Ghanaati H, Alavian SM, Nassiri Toosi M, Ebrahimi Daryani N, Jalali AH, Shakiba M, Hosseinverdi S. Management of liver hemangioma using trans-catheter arterial embolization. Hepat Mon. 2014 Dec 25;14(12):e25788. doi: 10.5812/hepatmon.25788. eCollection 2014 Dec. PubMed PMID: 25737731; PubMed Central PMCID: PMC4329237.
  • 72: Daram M, Montazeri G, Karimzadeh H, Malekzadeh R, Mahmoodi M, Goodarzi Z, Keyvani H, Mirmomen S, Alavian SM, Roggendorf M, Jazayeri SM. Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy. Iran J Basic Med Sci. 2014 Sep;17(9):638-45. PubMed PMID: 25691938; PubMed Central PMCID: PMC4322145.
  • 73: Pournik O, Dorri S, Zabolinezhad H, Alavian SM, Eslami S. A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach. Med J Islam Repub Iran. 2014 Oct 21;28:116. eCollection 2014. PubMed PMID: 25678995; PubMed Central PMCID: PMC4313459.
  • 74: Shirvani-Dastgerdi E, Amini-Bavil-Olyaee S, Alavian SM, Trautwein C, Tacke F. Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression. Clin Microbiol Infect. 2015 May;21(5):510.e11-23. doi: 10.1016/j.cmi.2014.12.008. Epub 2014 Dec 26. PubMed PMID: 25656625.
  • 75: Abbasinazari M, Alavian SM, Behnava B, Asgharinia M, Salimi S, Keshvari M, Mehrnoush L, Karim P. Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study. J Clin Diagn Res. 2014 Dec;8(12):HC16-9. doi: 10.7860/JCDR/2014/10403.5305. Epub 2014 Dec 5. PubMed PMID: 25653968; PubMed Central PMCID: PMC4316274.
  • 76: Pineda-Peña AC, Faria NR, Mina T, Amini-Bavil-Olyaee S, Alavian SM, Lemey P, Maes P, Van Ranst M, Pourkarim MR. Epidemiological history and genomic characterization of non-D1 HBV strains identified in Iran. J Clin Virol. 2015 Feb;63:38-41. doi: 10.1016/j.jcv.2014.12.010. Epub 2014 Dec 17. Erratum in: J Clin Virol. 2015 Aug;69:254. PubMed PMID: 25600602.
  • 77: Pourhoseingholi MA, Ashtari S, Alavian SM. Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients? Hepat Mon. 2014 Nov 23;14(11):e25540. doi: 10.5812/hepatmon.25540. eCollection 2014 Nov. PubMed PMID: 25598793; PubMed Central PMCID: PMC4286709.
  • 78: Ramezani-Binabaj M, Motalebi M, Karimi-Sari H, Rezaee-Zavareh MS, Alavian SM. Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis. Hepat Mon. 2014 Nov 1;14(11):e23235. doi: 10.5812/hepatmon.23235. eCollection 2014 Nov. Review. PubMed PMID: 25598791; PubMed Central PMCID: PMC4286712.
  • 79: Safari S, Motavaf M, Seyed Siamdoust SA, Alavian SM. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J. 2014 Sep 5;16(9):e20153. doi: 10.5812/ircmj.20153. eCollection 2014 Sep. Review. PubMed PMID: 25593732; PubMed Central PMCID: PMC4270648.
  • 80: Keshvari M, Alavian SM, Aghaee B, Behnava B, Mahdavi M, Fesharaki MG, Sharafi H. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization. Transfus Med. 2014 Dec;24(6):411-7. doi: 10.1111/tme.12163. Epub 2014 Dec 18. PubMed PMID: 25523297.
  • 81: Motavaf M, Safari S, Alavian SM. Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy. Acta Virol. 2014;58(4):301-8. Review. PubMed PMID: 25518710.
  • 82: Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon. 2014 Oct 11;14(10):e23539. doi: 10.5812/hepatmon.23539. eCollection 2014 Oct. Review. PubMed PMID: 25477978; PubMed Central PMCID: PMC4250965.
  • 83: Sharafi H, Alavian SM, Behnava B, Pouryasin A, Keshvari M. The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study. Hepat Mon. 2014 Oct 1;14(10):e22649. doi: 10.5812/hepatmon.22649. eCollection 2014 Oct. PubMed PMID: 25419220; PubMed Central PMCID: PMC4238152.
  • 84: Pishraft Sabet L, Taheri T, Memarnejadian A, Mokhtari Azad T, Asgari F, Rahimnia R, Alavian SM, Rafati S, Samimi Rad K. Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice. Hepat Mon. 2014 Oct 15;14(10):e22215. doi: 10.5812/hepatmon.22215. eCollection 2014 Oct. PubMed PMID: 25419219; PubMed Central PMCID: PMC4238154.
  • 85: Keshvari M, Alavian SM, Sharafi H. Differentiation of hepatitis B/hepatitis D coinfection and superinfection in asymptomatic blood donors: is it possible? APMIS. 2014 Oct;122(10):1042. PubMed PMID: 25356475.
  • 86: Pishraft-Sabet L, Kosinska AD, Rafati S, Bolhassani A, Taheri T, Memarnejadian A, Alavian SM, Roggendorf M, Samimi-Rad K. Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96. Arch Virol. 2015 Jan;160(1):141-52. doi: 10.1007/s00705-014-2243-8. Epub 2014 Oct 28. PubMed PMID: 25348271.
  • 87: Rezaee Zavareh MS, Alavian SM, Karimisari H, Shafiei M, Saiedi Hosseini SY. Occult hepatitis C virus infection in patients with autoimmune hepatitis. Hepat Mon. 2014 Aug 10;14(8):e16089. doi: 10.5812/hepatmon.16089. eCollection 2014 Aug. PubMed PMID: 25337141; PubMed Central PMCID: PMC4199148.
  • 88: Bokharaei-Salim F, Keyvani H, Salehi-Vaziri M, Sadeghi F, Monavari SH, Mehrnoush L, Alavian SM. Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients. Arch Virol. 2014 Nov;159(11):2893-9. doi: 10.1007/s00705-014-2133-0. Epub 2014 Aug 20. PubMed PMID: 25139545.
  • 89: Chenari M, Norouzi M, Ghalichi L, Rezaee A, Yari A, Alavian SM, Jazayeri SM. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area. J Med Virol. 2014 Nov;86(11):1861-7. doi: 10.1002/jmv.24046. Epub 2014 Aug 13. PubMed PMID: 25132488.
  • 90: Keshvari M, Hajibeigi B, Azarkeivan A, Keyvani H, Behnava B, Saiedi Hosseini SY, Sharafi H, Alavian SM. Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients. Transfus Med. 2014 Aug;24(4):227-32. doi: 10.1111/tme.12133. PubMed PMID: 25124072.
  • 91: Mahboobi N, Mahboobi N, Oliaei P, Alavian SM. Hepatitis C virus; its implication for endodontists. Iran Endod J. 2014 Summer;9(3):169-73. Epub 2014 Jul 5. Review. PubMed PMID: 25031588; PubMed Central PMCID: PMC4099946.
  • 92: Rahimzadeh P, Safari S, Faiz SH, Alavian SM. Anesthesia for patients with liver disease. Hepat Mon. 2014 Jul 1;14(7):e19881. doi: 10.5812/hepatmon.19881. eCollection 2014 Jul. Review. PubMed PMID: 25031586; PubMed Central PMCID: PMC4080095.
  • 93: Motavaf M, Safari S, Alavian SM. Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study. Hepat Mon. 2014 Jul 1;14(7):e19879. doi: 10.5812/hepatmon.19879. eCollection 2014 Jul. Review. PubMed PMID: 25031585; PubMed Central PMCID: PMC4080096.
  • 94: Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial. Nutrition. 2014 Jul-Aug;30(7-8):814-21. doi: 10.1016/j.nut.2013.11.008. Epub 2013 Dec 2. PubMed PMID: 24984998.
  • 95: Mohseni M, Safari S, Alavian SM. Volatile anesthetics in ischemic liver injury: enemy or friend? Hepat Mon. 2014 Jun 1;14(6):e19880. doi: 10.5812/hepatmon.19880. eCollection 2014 Jun. PubMed PMID: 24976844; PubMed Central PMCID: PMC4071358.
  • 96: Sargolzaee Aval F, Behnaz N, Raoufy MR, Alavian SM. Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network. Hepat Mon. 2014 Jun 1;14(6):e17028. doi: 10.5812/hepatmon.17028. eCollection 2014 Jun. PubMed PMID: 24976838; PubMed Central PMCID: PMC4071357.
  • 97: Poortahmasebi V, Alavian SM, Keyvani H, Norouzi M, Mahmoodi M, Jazayeri SM. Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer Prev. 2014;15(9):3879-84. PubMed PMID: 24935567.
  • 98: Sadeghi F, Bokharaei-Salim F, Salehi-Vaziri M, Monavari SH, Alavian SM, Salimi S, Vahabpour R, Keyvani H. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C. J Med Virol. 2014 Sep;86(9):1499-506. doi: 10.1002/jmv.23985. Epub 2014 May 29. PubMed PMID: 24889558.
  • 99: Sharafi H, Alavian SM, Keshvari M. Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment. J Formos Med Assoc. 2015 Feb;114(2):195-6. doi: 10.1016/j.jfma.2014.04.002. Epub 2014 May 20. PubMed PMID: 24853983.
  • 100: Farzi H, Ebrahimi Daryani N, Mehrnoush L, Salimi S, Alavian SM. Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection. Hepat Mon. 2014 May 1;14(5):e17537. doi: 10.5812/hepatmon.17537. eCollection 2014 May. Erratum in: Hepat Mon. 2014 May;14(5):e17537. PubMed PMID: 24829590; PubMed Central PMCID: PMC4013498.
  • 101: Heiat M, Ranjbar R, Alavian SM. Classical and modern approaches used for viral hepatitis diagnosis. Hepat Mon. 2014 Apr 16;14(4):e17632. doi: 10.5812/hepatmon.17632. eCollection 2014 Apr. Review. PubMed PMID: 24829586; PubMed Central PMCID: PMC4006100.
  • 102: Alavian SM, Banihabib N, Es Haghi M, Panahi F. Protective Effect of Cornus mas Fruits Extract on Serum Biomarkers in CCl4-Induced Hepatotoxicity in Male Rats. Hepat Mon. 2014 Apr 14;14(4):e10330. doi: 10.5812/hepatmon.10330. eCollection 2014 Apr. PubMed PMID: 24829584; PubMed Central PMCID: PMC4006099.
  • 103: Keshvari M, Sharafi H, Alavian SM. Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52]. Dig Liver Dis. 2014 Aug;46(8):761-2. doi: 10.1016/j.dld.2014.03.015. Epub 2014 May 9. PubMed PMID: 24815081.
  • 104: Motavaf M, Noorbakhsh F, Alavian SM, Sharifi Z. Distinct Toll-like Receptor 3 and 7 Expression in Peripheral Blood Mononuclear Cells From Patients with Chronic Hepatitis C Infection. Hepat Mon. 2014 Apr 7;14(4):e16421. doi: 10.5812/hepatmon.16421. eCollection 2014 Apr. PubMed PMID: 24748896; PubMed Central PMCID: PMC3989766.
  • 105: Keshvari M, Alavian SM, Sharafi H, Karimi G, Gholami Fesharaki M. Interferon alpha-2b therapy in chronic hepatitis delta. Hepat Mon. 2014 Mar 1;14(3):e15729. doi: 10.5812/hepatmon.15729. eCollection 2014 Mar. PubMed PMID: 24744790; PubMed Central PMCID: PMC3989544.
  • 106: Aalaei-Andabili SH, Behnava B, Salimi S, Sharafi H, Alavian SM. Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis. Hepat Mon. 2014 Mar 2;14(3):e15895. doi: 10.5812/hepatmon.15895. eCollection 2014 Mar. Erratum in: Hepat Mon. 2014 Sep;14(9):e22648. PubMed PMID: 24734092; PubMed Central PMCID: PMC3984474.
  • 107: Alavian SM. Comments on behavior of healthcare workers after injuries from sharp instruments. Trauma Mon. 2014 Feb;19(1):e17040. doi: 10.5812/traumamon.17040. Epub 2014 Jan 25. PubMed PMID: 24719829; PubMed Central PMCID: PMC3955928.
  • 108: Alavian SM. An unbelievable fact on "dialysis centers without hepatitis C infection". Nephrourol Mon. 2014 Mar 1;6(2):e17998. doi: 10.5812/numonthly.17998. eCollection 2014 Mar. PubMed PMID: 24719822; PubMed Central PMCID: PMC3968971.
  • 109: Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J. 2014 Mar;29(2):92-6. doi: 10.5001/omj.2014.23. PubMed PMID: 24715933; PubMed Central PMCID: PMC3976723.
  • 110: Alavian SM. Vaccination in Health Care Workers Should be Following in our Country Now?! Iran Red Crescent Med J. 2013 Dec;15(12):e17145. doi: 10.5812/ircmj.17145. Epub 2013 Dec 5. PubMed PMID: 24693406; PubMed Central PMCID: PMC3955521.
  • 111: Einollahi B, Ghadian A, Ghamar-Chehreh E, Alavian SM. Non-viral related liver enzymes elevation after kidney transplantation. Hepat Mon. 2014 Feb 5;14(2):e9036. doi: 10.5812/hepatmon.9036. eCollection 2014 Feb. PubMed PMID: 24693313; PubMed Central PMCID: PMC3950572.
  • 112: Keshvari M, Alavian SM, Sharafi H. How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level? Hepat Mon. 2014 Feb 5;14(2):e15285. doi: 10.5812/hepatmon.15285. eCollection 2014 Feb. PubMed PMID: 24693309; PubMed Central PMCID: PMC3950628.
  • 113: Hashemi Kani A, Alavian SM, Haghighatdoost F, Azadbakht L. Diet macronutrients composition in nonalcoholic Fatty liver disease: a review on the related documents. Hepat Mon. 2014 Feb 17;14(2):e10939. doi: 10.5812/hepatmon.10939. eCollection 2014 Feb. Review. PubMed PMID: 24693306; PubMed Central PMCID: PMC3950571.
  • 114: Keshvari M, Alavian SM, Sharafi H. How can the IL28B polymorphisms with linkage disequilibrium affect the natural course of hepatitis B inversely? Liver Int. 2014 Aug;34(7):1127. doi: 10.1111/liv.12515. Epub 2014 Mar 24. PubMed PMID: 24576012.
  • 115: Alavian SM, Jazayeri SM. Prevalence of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population. Asian Pac J Cancer Prev. 2014;15(2):1065. PubMed PMID: 24568453.
  • 116: Pourkarim MR, Vergote V, Amini-Bavil-Olyaee S, Sharifi Z, Sijmons S, Lemey P, Maes P, Alavian SM, Van Ranst M. Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1. J Med Virol. 2014 May;86(5):745-57. doi: 10.1002/jmv.23864. Epub 2014 Feb 14. PubMed PMID: 24532489.
  • 117: Keshvari M, Alavian SM, Sharafi H. What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients? Clinics (Sao Paulo). 2014 Feb;69(2):152. doi: 10.6061/clinics/2014(02)13. PubMed PMID: 24519208; PubMed Central PMCID: PMC3912342.
  • 118: Pournik O, Alavian SM, Ghalichi L, Seifizarei B, Mehrnoush L, Aslani A, Anjarani S, Eslami S. Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies. Hepat Mon. 2014 Jan 3;14(1):e15167. doi: 10.5812/hepatmon.15167. eCollection 2014 Jan. PubMed PMID: 24497882; PubMed Central PMCID: PMC3909644.
  • 119: Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, Dadmanesh M, Roayaei Ardakany A, Motedayen MH, Sazmand A. GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study. Hepat Mon. 2013 Dec 30;13(12):e15342. doi: 10.5812/hepatmon.15342. Review. PubMed PMID: 24403917; PubMed Central PMCID: PMC3877655.
  • 120: Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon. 2013 Dec 16;13(12):e14324. doi: 10.5812/hepatmon.14324. eCollection 2013. PubMed PMID: 24403914; PubMed Central PMCID: PMC3877657.
  • 121: Keshvari M, Pouryasin A, Behnava B, Sharafi H, Hajarizadeh B, Alavian SM. Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C. Aliment Pharmacol Ther. 2014 Feb;39(3):343. doi: 10.1111/apt.12589. PubMed PMID: 24397325.
  • 122: Keshvari M, Sharafi H, Hajarizadeh B, Alavian SM. Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? Liver Int. 2014 Jul;34(6):964. doi: 10.1111/liv.12464. Epub 2014 Feb 7. PubMed PMID: 24397313.
  • 123: Lankarani KB, Alavian SM. Lessons learned from past cholera epidemics, interventions which are needed today. J Res Med Sci. 2013 Aug;18(8):630-1. PubMed PMID: 24379835; PubMed Central PMCID: PMC3872598.
  • 124: Alavian SM. Sofosbuvir has come out of the magic box. Hepat Mon. 2013 Dec 16;13(12):e16916. doi: 10.5812/hepatmon.16916. eCollection 2013. PubMed PMID: 24358046; PubMed Central PMCID: PMC3867003.
  • 125: Mahdavi M, Amirrasouli H, Alavian SM, Behnava B, Kazerouni F, Keshvari M, Namaki S, Gholami Fesharaki M, Rahimipour H, Mohammadzade J, Zohrehbandian F, Mahdavipour F. Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study. Hepat Mon. 2013 Nov 23;13(11):e11903. doi: 10.5812/hepatmon.11903. eCollection 2013. PubMed PMID: 24348645; PubMed Central PMCID: PMC3858956.
  • 126: Rostami-Nejad M, Haldane T, Aldulaimi D, Alavian SM, Zali MR, Rostami K. The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement. Hepat Mon. 2013 Oct 13;13(10):e11893. doi: 10.5812/hepatmon.11893. Review. PubMed PMID: 24348636; PubMed Central PMCID: PMC3842525.
  • 127: Motavaf M, Safari S, Saffari Jourshari M, Alavian SM. Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. Acta Virol. 2013;57(4):389-96. Review. PubMed PMID: 24294951.
  • 128: Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Nasseri S. Distribution of hepatitis C virus genotypes among azerbaijani patients in capital city of iran-tehran. Hepat Mon. 2013 Sep 1;13(9):e13699. doi: 10.5812/hepatmon.13699. eCollection 2013. PubMed PMID: 24282427; PubMed Central PMCID: PMC3830518.
  • 129: Mehrazmay A, Alavian SM, Moradi-Lakeh M, Mokhtari Payam M, Hashemi-Meshkini A, Behnava B, Miri SM, Karimi Elizee P, Tabatabaee SV, Keshvari M, Bagheri Lankarani K. Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran. Hepat Mon. 2013 Sep 1;13(9):e10236. doi: 10.5812/hepatmon.10236. eCollection 2013. PubMed PMID: 24282420; PubMed Central PMCID: PMC3830516.
  • 130: Motavaf M, Safari S, Alavian SM. Understanding of molecular pain medicine: genetic basis of variation in pain sensation and analgesia response. Anesth Pain Med. 2013 Winter;2(3):104-6. doi: 10.5812/aapm.8583. Epub 2013 Jan 1. PubMed PMID: 24244917; PubMed Central PMCID: PMC3821128.
  • 131: Alavian SM, Mahboobi N, Mahboobi N, Karayiannis P. Oral conditions associated with hepatitis C virus infection. Saudi J Gastroenterol. 2013 Nov-Dec;19(6):245-51. doi: 10.4103/1319-3767.121032. Review. PubMed PMID: 24195977; PubMed Central PMCID: PMC3958971.
  • 132: Akbarzadeh Baghban A, Pourhoseingholi A, Zayeri F, Jafari AA, Alavian SM. Application of zero-inflated poisson mixed models in prognostic factors of hepatitis C. Biomed Res Int. 2013;2013:403151. doi: 10.1155/2013/403151. Epub 2013 Oct 1. PubMed PMID: 24195069; PubMed Central PMCID: PMC3806337.
  • 133: Pourkarim MR, Sharifi Z, Soleimani A, Amini-Bavil-Olyaee S, Elsadek Fakhr A, Sijmons S, Vercauteren J, Karimi G, Lemey P, Maes P, Alavian SM, Van Ranst M. Evolutionary analysis of HBV "S" antigen genetic diversity in Iranian blood donors: a nationwide study. J Med Virol. 2014 Jan;86(1):144-55. doi: 10.1002/jmv.23798. Epub 2013 Oct 22. PubMed PMID: 24150816.
  • 134: Abbasinazari M, Behnava B, Panahi Y, Hajhossein Talasaz A, Salimi S, Keshvari M, Mehrnoush L, Karim Elizee P, Gholami Fesharaki M, Asgharinia M, Alavian SM. Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference? Hepat Mon. 2013 Aug 12;13(8):e11138. doi: 10.5812/hepatmon.11138. eCollection 2013. PubMed PMID: 24130600; PubMed Central PMCID: PMC3796196.
  • 135: Ghamari S, Alavian SM, Rizzetto M, Olivero A, Smedile A, Khedive A, Alavian SE, Zolfaghari MR, Jazayeri SM. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures. Hepat Mon. 2013 Aug 16;13(8):e6731. doi: 10.5812/hepatmon.6731. eCollection 2013. PubMed PMID: 24098308; PubMed Central PMCID: PMC3787685.
  • 136: Keyvani H, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, Sadigh ZA, Alavian SM. Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat Mon. 2013 Aug 5;13(8):e11290. doi: 10.5812/hepatmon.11290. eCollection 2013. PubMed PMID: 24082889; PubMed Central PMCID: PMC3785931.
  • 137: Alavian SM, Mirahmadizadeh A, Javanbakht M, Keshtkaran A, Heidari A, Mashayekhi A, Salimi S, Hadian M. Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users. Hepat Mon. 2013 Aug 17;13(8):e12411. doi: 10.5812/hepatmon.12411. eCollection 2013. PubMed PMID: 24069039; PubMed Central PMCID: PMC3782738.
  • 138: Sali S, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N. Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up. Hepat Mon. 2013 Jul 8;13(7):e8743. doi: 10.5812/hepatmon.8743. eCollection 2013. PubMed PMID: 24066002; PubMed Central PMCID: PMC3776148.
  • 139: Amini-Bavil-Olyaee S, Tacke F, Alavian SM. HBV Subgenotypes D1, D2, D-del! Are 'Old' Genotyping Methods Interpreted Correctly? Hepat Mon. 2013 Jul 1;13(7):e13048. doi: 10.5812/hepatmon.13048. eCollection 2013. PubMed PMID: 24066000; PubMed Central PMCID: PMC3779349.
  • 140: Hashemi Kani A, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD). Hepat Mon. 2013 Jul 13;13(7):e10943. doi: 10.5812/hepatmon.10943. eCollection 2013. PubMed PMID: 24065998; PubMed Central PMCID: PMC3776150.
  • 141: Elizee PK, Alavian SM. Prevention of hepatitis a virus infection, need to vaccinate or not? Int J Prev Med. 2013 Aug;4(8):863-5. PubMed PMID: 24049610; PubMed Central PMCID: PMC3775161.
  • 142: Ghaziasadi A, Alavian SM, Norouzi M, Fazeli Z, Jazayeri SM. Mutational analysis of HBs Ag-positive mothers and their infected children despite immunoprophylaxis. Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):352-60. PubMed PMID: 23996711.
  • 143: Vakili Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E, Aghasadeghi MR. Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon. 2013 May 29;13(5):e10134. doi: 10.5812/hepatmon.10134. eCollection 2013 May. PubMed PMID: 23967017; PubMed Central PMCID: PMC3741907.
  • 144: Ashtari S, Vahedi M, Pourhoseingholi MA, Karkhane M, Kimiia Z, Pourhoseingholi A, Safaee A, Moghimi-Dehkordi B, Zali MR, Alavian SM. Direct medical care costs associated with patients diagnosed with chronic HCV. Hepat Mon. 2013 Apr 28;13(5):e8415. doi: 10.5812/hepatmon.8415. Print 2013 May. PubMed PMID: 23930132; PubMed Central PMCID: PMC3736623.
  • 145: Pournik O, Alavian SM, Ghalichi L, Hajibeigi B, Razavi AR, Eslami S. Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis d coinfection: a data-mining approach. Hepat Mon. 2013 May 23;13(5):e7652. doi: 10.5812/hepatmon.7652. Print 2013 May. PubMed PMID: 23922559; PubMed Central PMCID: PMC3732666.
  • 146: Ghamar Chehreh ME, Vahedi M, Pourhoseingholi MA, Ashtari S, Khedmat H, Amin M, Zali MR, Alavian SM. Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation. Hepat Mon. 2013 May 8;13(5):e7382. doi: 10.5812/hepatmon.7382. Print 2013 May. PubMed PMID: 23914227; PubMed Central PMCID: PMC3728974.
  • 147: Rizzetto M, Alavian SM. Hepatitis delta: the rediscovery. Clin Liver Dis. 2013 Aug;17(3):475-87. doi: 10.1016/j.cld.2013.05.007. Epub 2013 Jul 3. Review. PubMed PMID: 23905817.
  • 148: Alavian SM, Tabatabaei SV, Behnava B, Rizzetto M. Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis. J Res Med Sci. 2012 Oct;17(10):967-74. PubMed PMID: 23825999; PubMed Central PMCID: PMC3698658.
  • 149: Khedive A, Sanei-Moghaddam I, Alavian SM, Saberfar E, Norouzi M, Judaki M, Ghamari S, Jazayeri SM. Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran. Arch Iran Med. 2013 Jul;16(7):385-9. doi: 013167/AIM.005. PubMed PMID: 23808774.
  • 150: Khedive A, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Judaki MA, Ghamari S, Daram M, Mahabadi M, Fazeli Z, Goodarzi Z, Poortahmasebi V, Jazayeri SM. Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study. J Viral Hepat. 2013 Jul;20(7):494-501. doi: 10.1111/jvh.12045. Epub 2013 Apr 25. PubMed PMID: 23730843.
  • 151: Alavian SM. Collecting blood just from voluntary repeated blood donors is the wisdom strategy in Vietnam. Indian J Med Res. 2013 Apr;137(4):813. PubMed PMID: 23703354; PubMed Central PMCID: PMC3724267.
  • 152: Ataei B, Shirani K, Alavian SM, Ataie M. Evaluation of Knowledge and Practice of Hairdressers in Women's Beauty Salons in Isfahan About Hepatitis B, Hepatitis C, and AIDS in 2010 and 2011. Hepat Mon. 2013 Mar 6;13(3):e6215. doi: 10.5812/hepatmon.6215. Print 2013 Mar. PubMed PMID: 23658593; PubMed Central PMCID: PMC3644795.
  • 153: Einollahi B, Alavian SM. Hepatitis B virus infection: need for more attention in hemodialysis patients. Saudi J Kidney Dis Transpl. 2013 May;24(3):587-8. PubMed PMID: 23640639.
  • 154: Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nourani MR, Khani S, Alavian SM. Probiotic as a novel treatment strategy against liver disease. Hepat Mon. 2013 Feb 25;13(2):e7521. doi: 10.5812/hepatmon.7521. Print 2013 Feb. PubMed PMID: 23610585; PubMed Central PMCID: PMC3631524.
  • 155: Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM. Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients. Hepat Mon. 2013 Jan 20;13(1):e6712. doi: 10.5812/hepatmon.6712. Print 2013 Jan. PubMed PMID: 23596461; PubMed Central PMCID: PMC3626233.
  • 156: Samimi-Rad K, Asgari F, Nasiritoosi M, Esteghamati A, Azarkeyvan A, Eslami SM, Zamani F, Magnius L, Alavian SM, Norder H. Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains. Hepat Mon. 2013 Jan 23;13(1):e7699. doi: 10.5812/hepatmon.7699. Print 2013 Jan. PubMed PMID: 23585766; PubMed Central PMCID: PMC3622054.
  • 157: Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis. Hepat Mon. 2013 Jan;13(1):e8210. doi: 10.5812/hepatmon.8210. Epub 2013 Jan 6. PubMed PMID: 23554822; PubMed Central PMCID: PMC3609404.
  • 158: Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013 Jan;13(1):e7991. doi: 10.5812/hepatmon.7991. Epub 2013 Jan 20. PubMed PMID: 23550108; PubMed Central PMCID: PMC3582303.
  • 159: Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Salimi S, Mehrnoush L, Fatemi A. Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals. Hepat Mon. 2012 Dec;12(12):e8387. doi: 10.5812/hepatmon.8387. Epub 2012 Dec 22. PubMed PMID: 23550102; PubMed Central PMCID: PMC3580886.
  • 160: Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature. J Gastrointestin Liver Dis. 2013 Mar;22(1):79-86. Review. PubMed PMID: 23539395.
  • 161: Hatami H, Salehi M, Sanei E, Khosravi S, Alavian SM. Intra-familial Transmission of Hepatitis B virus Infection in Zahedan. Iran Red Crescent Med J. 2013 Jan;15(1):4-8. doi: 10.5812/ircmj.2282. Epub 2013 Jan 5. PubMed PMID: 23487536; PubMed Central PMCID: PMC3589768.
  • 162: Lankarani KB, Alavian SM, Peymani P. Health in the Islamic Republic of Iran, challenges and progresses. Med J Islam Repub Iran. 2013 Feb;27(1):42-9. PubMed PMID: 23479501; PubMed Central PMCID: PMC3592943.
  • 163: Ghasemi S, Kabir A, Ansari Jafari M, Jalali M, Amini A, Faghihi-Kashani AH, Alavian SM. Psychometric Properties of a Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis. Hepat Mon. 2012 Dec;12(12):e7650. doi: 10.5812/hepatmon.7650. Epub 2012 Dec 31. PubMed PMID: 23443850; PubMed Central PMCID: PMC3580055.
  • 164: Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, Shakiba M. Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. Iran J Radiol. 2012 Nov;9(4):167-77. doi: 10.5812/iranjradiol.8242. Epub 2012 Nov 20. PubMed PMID: 23407596; PubMed Central PMCID: PMC3569547.
  • 165: Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol. 2013 Mar-Apr;12(2):213-9. PubMed PMID: 23396732.
  • 166: Pournik O, Alavian SM, Eslami S. Can we accurately assess liver fibrosis with Fibroscan® using fewer valid measurements? Yonsei Med J. 2013 Mar 1;54(2):541-2. doi: 10.3349/ymj.2013.54.2.541. PubMed PMID: 23364995; PubMed Central PMCID: PMC3575979.
  • 167: Sayyad B, Alavian SM, Najafi F, Mokhtari Azad T, Ari Tabarestani MH, Shirvani M, Behnava B, Afshrian M, Vaziri S, Janbakhsh AR, Mansouri F, Kaviani Sh. Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection. Iran Red Crescent Med J. 2012 Oct;14(10):623-30. Epub 2012 Oct 30. PubMed PMID: 23285414; PubMed Central PMCID: PMC3518979.
  • 168: Zayeri F, Chaibakhsh S, Pourhoseingholi A, Baghban AA, Alavian SM. Random effect model for identifying related factors to virological response in HCV patients. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S65-9. PubMed PMID: 24834290; PubMed Central PMCID: PMC4017535.
  • 169: Pourhoseingholi A, Baghban AA, Zayeri F, Alavian SM, Vahedi M. Statistical count models for prognosis the risk factors of hepatitis C. Gastroenterol Hepatol Bed Bench. 2013 Winter;6(1):41-7. PubMed PMID: 24834244; PubMed Central PMCID: PMC4017489.
  • 170: Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, Abolghasemi H. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012 Nov;3(11):770-5. PubMed PMID: 23189228; PubMed Central PMCID: PMC3506088.
  • 171: Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, Alavian S, Judaki M, Ghamari S, Namazi A, Rahimnia R, Khedive A, Jazayeri S. Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iran J Public Health. 2012;41(3):104-11. Epub 2012 Mar 31. PubMed PMID: 23113154; PubMed Central PMCID: PMC3481712.
  • 172: Rostami Nejad M, Alavian SM. Celiac disease and abnormal liver function test. Int J Prev Med. 2012 Oct;3(10):745-6. PubMed PMID: 23112905; PubMed Central PMCID: PMC3483006.
  • 173: Alavi Moghaddam M, Zali MR, Aalaei Andabili SH, Derakhshan F, Miri SM, Alavian SM. High Rate of Virological Response to Peginterferon α-2a-Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C. Iran Red Crescent Med J. 2012 Aug;14(8):466-9. Epub 2012 Aug 30. PubMed PMID: 23105981; PubMed Central PMCID: PMC3470839.
  • 174: Elizee PK, Alavian SM, Miri SM. Letter to the editor: the increasing hepatitis a incidence in Korea: is it possible within a limited time? J Prev Med Public Health. 2012 Sep;45(5):329-30; author reply 331-2. doi: 10.3961/jpmph.2012.45.5.329. Epub 2012 Sep 28. PubMed PMID: 23091659; PubMed Central PMCID: PMC3469816.
  • 175: Sayad B, Alavian SM, Najafi F, Soltani B, Shirvani M, Janbakhsh A, Mansouri F, Afsharian M, Vaziri S, Alikhani A, Bashiri H. Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial. Hepat Mon. 2012 Sep;12(9):e6234. doi: 10.5812/hepatmon.6234. Epub 2012 Sep 30. PubMed PMID: 23087761; PubMed Central PMCID: PMC3475133.
  • 176: Namazee N, Sali S, Asadi S, Shafiei M, Behnava B, Alavian SM. Real response to therapy in chronic hepatitis C virus patients: a study from iran. Hepat Mon. 2012 Sep;12(9):e6151. doi: 10.5812/hepatmon.6151. Epub 2012 Sep 15. PubMed PMID: 23087759; PubMed Central PMCID: PMC3475060.
  • 177: Alavian SM, Miri SM, Hollinger FB, Jazayeri SM. Occult Hepatitis B (OBH) in Clinical Settings. Hepat Mon. 2012 Aug;12(8):e6126. doi: 10.5812/hepatmon.6126. Epub 2012 Aug 25. PubMed PMID: 23087749; PubMed Central PMCID: PMC3475016.
  • 178: Aalaei-Andabili SH, Alavian SM. Principles of meta-analysis should be well understood. Obes Surg. 2012 Dec;22(12):1926-7. doi: 10.1007/s11695-012-0789-7. PubMed PMID: 23054577.
  • 179: Alavian SM. Persistence of anti-HBs antibody in children whom vaccinated during infantile period and need to booster needs more discussion. Eur J Pediatr. 2013 Jun;172(6):855. doi: 10.1007/s00431-012-1850-1. Epub 2012 Oct 7. PubMed PMID: 23052620.
  • 180: Motavaf M, Safari S, Alavian SM. Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C. J Viral Hepat. 2012 Nov;19(11):757-65. doi: 10.1111/jvh.12006. Review. PubMed PMID: 23043382.
  • 181: Mahboobi N, Tabatabaei SV, Blum HE, Alavian SM. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature. Transpl Infect Dis. 2012 Oct;14(5):445-51. doi: 10.1111/j.1399-3062.2012.00782.x. Epub 2012 Sep 12. Review. PubMed PMID: 22970743.
  • 182: Bokharaei-Salim F, Alavian SM. HCV genotypes distribution pattern in India. Indian J Med Res. 2012 Aug;136(2):306-7; author reply 307-8. PubMed PMID: 22960903; PubMed Central PMCID: PMC3461749.
  • 183: Alavian SM. Seronegative anti-hepatitis C virus antibody in hemodialysis patients. Hemodial Int. 2013 Apr;17(2):328. doi: 10.1111/j.1542-4758.2012.00738.x. Epub 2012 Sep 4. PubMed PMID: 22947268.
  • 184: Aalaei-Andabili SH, Alavian SM. Important steps for a reliable meta-analysis. Lancet Infect Dis. 2012 Sep;12(9):663. doi: 10.1016/S1473-3099(12)70200-1. PubMed PMID: 22917101.
  • 185: Alavian SM. Occult hepatitis B in thalassemia: a need for further study. J Infect Dev Ctries. 2012 Aug 21;6(8):650-1. doi: 10.3855/jidc.2864. PubMed PMID: 22910573.
  • 186: Alavian SM. On the occasion of the world hepatitis day: world hepatitis day and our achievements and responsibilities in iran. Int J Prev Med. 2012 Jul;3(7):437-9. PubMed PMID: 22891143; PubMed Central PMCID: PMC3415182.
  • 187: Alavian SM. Hepatitis B virus and HIV coinfections can be interpreted in different ways. J Infect Chemother. 2013 Feb;19(1):183. doi: 10.1007/s10156-012-0462-z. Epub 2012 Aug 11. PubMed PMID: 22886448.
  • 188: Aalaei-Andabili SH, Mehrnoush L, Salimi S, Shafiei M, Alavian SM. Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases. Hepat Mon. 2012 Jun;12(6):408-10. doi: 10.5812/hepatmon.6685. Epub 2012 Jun 30. PubMed PMID: 22879831; PubMed Central PMCID: PMC3412558.
  • 189: Tabatabaei SV, Alavian SM, Keshvari M, Behnava B, Miri SM, Karimi Elizee P, Zamani F, Amini Kafiabad S, Gharehbaghian A, Hajibeigy B, Lankarani KB. Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy. Hepat Mon. 2012 Jun;12(6):372-81. doi: 10.5812/hepatmon.6592. Epub 2012 Jun 30. PubMed PMID: 22879826; PubMed Central PMCID: PMC3412553.
  • 190: Bozorgi SH, Ramezani H, Nooranipour M, Ahmadi M, Baghernejad A, Mostajeri A, Kargar-Fard H, Sadri M, Alavian SM. Risk factors of viral hepatitis: yet to explore. Transfus Apher Sci. 2012 Oct;47(2):145-9. doi: 10.1016/j.transci.2012.06.023. Epub 2012 Aug 1. PubMed PMID: 22858443.
  • 191: Salehi M, Alavian SM, Tabatabaei SV, Izadi Sh, Sanei Moghaddam E, Amini Kafi-Abad S, Gharehbaghian A, Khosravi S, Abolghasemi H. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012 May;14(5):283-8. Epub 2012 May 30. PubMed PMID: 22829987; PubMed Central PMCID: PMC3398635.
  • 192: Alavian SM, Taheri S. Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update. Iran J Kidney Dis. 2012 Jul;6(4):236-54. Review. PubMed PMID: 22797092.
  • 193: Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013 Jul;57(3):201-8. doi: 10.1016/j.jcv.2012.04.027. Epub 2012 Jul 11. Review. PubMed PMID: 22789139.
  • 194: Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012 May;12(5):339-43. doi: 10.5812/hepatmon.5969. Epub 2012 May 30. PubMed PMID: 22783346; PubMed Central PMCID: PMC3389360.
  • 195: Aalaei-Andabili SH, Alavian SM. Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis. Vaccine. 2012 Aug 17;30(38):5595-602. doi: 10.1016/j.vaccine.2012.06.063. Epub 2012 Jul 7. Review. PubMed PMID: 22781305.
  • 196: Ranjbar R, Davari A, Izadi M, Jonaidi N, Alavian SM. HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article. Iran Red Crescent Med J. 2011 Dec;13(12):855-62. Epub 2011 Dec 1. PubMed PMID: 22737429; PubMed Central PMCID: PMC3371904.
  • 197: Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AN, Hassanpour G, Alavian SM, Asgari F. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Arch Virol. 2012 Oct;157(10):1959-65. Epub 2012 Jun 13. PubMed PMID: 22695769.
  • 198: Alavian SM, Aalaei-Andabili SH. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis. Hepat Mon. 2012 Apr;12(4):244-52. doi: 10.5812/hepatmon.844. Epub 2012 Apr 30. PubMed PMID: 22690231; PubMed Central PMCID: PMC3360933.
  • 199: Alavian SM. Occult hepatitis B virus infection among hemodialysis patients. Hepat Mon. 2012 Apr;12(4):242-3. doi: 10.5812/hepatmon.869. Epub 2012 Apr 30. PubMed PMID: 22690230; PubMed Central PMCID: PMC3360932.
  • 200: Alavian SM, Miri SM, Jazayeri SM. Hepatitis B vaccine: prophylactic, therapeutic, and diagnostic dilemma. Minerva Gastroenterol Dietol. 2012 Jun;58(2):167-78. Review. PubMed PMID: 22643598.
  • 201: Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol. 2012 Sep;57(3):515-21. doi: 10.1016/j.jhep.2012.04.021. Epub 2012 May 19. PubMed PMID: 22617152.
  • 202: Ghaziasadi A, Ziaee M, Norouzi M, Malekzadeh R, Alavian SM, Saberfar E, Judaki MA, Ghamari S, Khedive A, Namazi A, Rahimnia R, Jazayeri SM. The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan Province, North-East of Iran. Acta Med Iran. 2012;50(4):265-72. PubMed PMID: 22592577.
  • 203: Samimi-Rad K, Hosseini M, Mobeini G, Asgari F, Alavian SM, Tahaei ME, Salari H. Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran. East Mediterr Health J. 2012 Mar;18(3):227-35. PubMed PMID: 22574475.
  • 204: Mahboobi N, Esmaeili S, Safari S, Habibollahi P, Dabbagh A, Alavian SM. Halothane: how should it be used in a developing country? East Mediterr Health J. 2012 Feb;18(2):159-64. Review. PubMed PMID: 22571093.
  • 205: Ghadir MR, Belbasi M, Heidari A, Sarkeshikian SS, Kabiri A, Ghanooni AH, Iranikhah A, Vaez-Javadi M, Alavian SM. Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iran. Hepat Mon. 2012 Mar;12(3):205-8. doi: 10.5812/hepatmon.847. Epub 2012 Mar 28. PubMed PMID: 22550529; PubMed Central PMCID: PMC3339421.
  • 206: Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Mehrnoush L, Salimi S, Kheradvar O. Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response. Hepat Mon. 2012 Mar;12(3):190-5. doi: 10.5812/hepatmon.849. Epub 2012 Mar 28. PubMed PMID: 22550527; PubMed Central PMCID: PMC3339419.
  • 207: Dindoost P, Jazayeri SM, Alavian SM. Hepatitis B immune globulin in liver transplantation prophylaxis: an update. Hepat Mon. 2012 Mar;12(3):168-76. doi: 10.5812/hepatmon.832. Epub 2012 Mar 28. PubMed PMID: 22550524; PubMed Central PMCID: PMC3339416.
  • 208: Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, Kabiri A, Ghanooni AH, Iranikhah A, Alavian SM. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012 Feb;12(2):112-7. doi: 10.5812/hepatmon.822. Epub 2012 Feb 29. PubMed PMID: 22509188; PubMed Central PMCID: PMC3321318.
  • 209: Shafiei M, Alavian SM. Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better management. Hepat Mon. 2012 Feb;12(2):73-6. doi: 10.5812/hepatmon.840. Epub 2012 Feb 29. PubMed PMID: 22509182; PubMed Central PMCID: PMC3321324.
  • 210: Nejad MR, Alavian SM. Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not? Bratisl Lek Listy. 2012;113(4):251. PubMed PMID: 22502761.
  • 211: Jazayeri SM, Alavian SM. Hepatitis B virus variants in HBV mono-infected versus HBV/HIV co-infected patients. Curr HIV Res. 2012 Apr;10(3):245-6. PubMed PMID: 22497696.
  • 212: Alavian SM, Jazayeri SM. Commentary on "risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States". Am J Gastroenterol. 2012 Apr;107(4):635. doi: 10.1038/ajg.2012.22. PubMed PMID: 22475970.
  • 213: Alavian SM, Bagheri Ankarani K. letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30. Middle East J Dig Dis. 2012 Apr;4(2):133-4. PubMed PMID: 24829647; PubMed Central PMCID: PMC4017683.
  • 214: Aalaei-Andabili SH, Alavian SM. High-quality meta-analyses are required for development of evidence in medicine. J Infect Dis. 2012 May 1;205(9):1472; author reply 1473. doi: 10.1093/infdis/jis224. Epub 2012 Mar 29. PubMed PMID: 22457296.
  • 215: Zobeiri M, Adibi P, Alavian SM. Intravenous drug use and hepatitis C virus in iran. Hepat Mon. 2012 Jan;12(1):9-10. doi: 10.5812/kowsar.1735143X.797. Epub 2012 Jan 20. PubMed PMID: 22451838; PubMed Central PMCID: PMC3298870.
  • 216: Motavaf M, Alavian SM. RNA interference: a promising approach for the treatment of viral hepatitis. Hepat Mon. 2012 Jan;12(1):7-8. doi: 10.5812/kowsar.1735143X.812. Epub 2012 Jan 20. PubMed PMID: 22451837; PubMed Central PMCID: PMC3298869.
  • 217: Sayad B, Anvari FA, Alavian SM, Norouzi M, Hamzelooie M, Shirvani M, Pourhoseingholi A, Khedive A, Ghamari S, Judaki MA, Jazayeri SM. Correlation of Hepatitis B surface antigen mutations with clinical status of the chronically infected patients from Kermanshah, West of Iran. Minerva Gastroenterol Dietol. 2012 Mar;58(1):9-18. PubMed PMID: 22419000.
  • 218: Alavian SM. Transmission of HBV infection from mothers HBsAg positive to infants need to more attention. J Clin Virol. 2012 Jun;54(2):201. doi: 10.1016/j.jcv.2012.02.001. Epub 2012 Mar 13. PubMed PMID: 22418455.
  • 219: Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei Andabili SH. Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis. Hepat Mon. 2011 Dec;11(12):960-7. doi: 10.5812/kowsar.1735143X.805. Epub 2011 Dec 20. PubMed PMID: 22368679; PubMed Central PMCID: PMC3282028.
  • 220: Sharafi H, Alavian SM. IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients. Hepat Mon. 2011 Dec;11(12):958-9. doi: 10.5812/kowsar.1735143X.794. Epub 2011 Dec 20. PubMed PMID: 22368678; PubMed Central PMCID: PMC3282027.
  • 221: Alavian SM. Herbal medicine and liver disease, for any conclusion we need to do more studies. J Res Med Sci. 2011 Jul;16(7):974-5. PubMed PMID: 22279469; PubMed Central PMCID: PMC3263114.
  • 222: Alavian SM, Tabatabaei SV, Behnava B. Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis. J Viral Hepat. 2012 Feb;19(2):88-93. doi: 10.1111/j.1365-2893.2011.01532.x. Epub 2011 Oct 30. Review. PubMed PMID: 22239498.
  • 223: Vahedi M, Pourhoseingholi A, Ashtari S, Pourhoseingholi MA, Karkhane M, Moghimi-Dehkordi B, Safaee A, Kimia Z, Alavian SM. Using statistical models to assess medical cost of hepatitis C virus. Gastroenterol Hepatol Bed Bench. 2012 Winter;5(Suppl 1):S31-6. PubMed PMID: 24834235; PubMed Central PMCID: PMC4017486.
  • 224: Alavian SM. One swallow doesn't bring spring, reply to Khamesipour et al. Transfus Apher Sci. 2012 Feb;46(1):103. doi: 10.1016/j.transci.2011.11.015. Epub 2011 Dec 19. PubMed PMID: 22188928.
  • 225: Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Oral fluid and hepatitis A, B and C: a literature review. J Oral Pathol Med. 2012 Aug;41(7):505-16. doi: 10.1111/j.1600-0714.2011.01123.x. Epub 2011 Dec 22. Review. PubMed PMID: 22188507.
  • 226: Alavian SM, Mahboobi N, Mahboobi N, Savadrudbari MM, Azar PS, Daneshvar S. Iranian dental students' knowledge of hepatitis B virus infection and its control practices. J Dent Educ. 2011 Dec;75(12):1627-34. PubMed PMID: 22184603.
  • 227: Alavian SM. Seroprevalence of hepatitis B and C infection markers among children and adolescents in the southern Brazilian region. Rev Inst Med Trop Sao Paulo. 2011 Nov-Dec;53(6):347. PubMed PMID: 22183461.
  • 228: Alavian SM, Tabatabaei SV, Behnava B, Mahboobi N. Optimal duration of treatment for HCV genotype 1 infection in slow responders: a meta-analysis. Hepat Mon. 2011 Aug;11(8):612-9. PubMed PMID: 22140384; PubMed Central PMCID: PMC3227488.
  • 229: Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, Los M, Ghavami S. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. J Viral Hepat. 2011 Dec;18(12):821-30. doi: 10.1111/j.1365-2893.2011.01530.x. Epub 2011 Oct 13. Review. PubMed PMID: 22093031.
  • 230: Alavian SM. Re: Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana'a, Yemen-We need to work much harder to control hepatitis B virus infection in developing countries. Sultan Qaboos Univ Med J. 2011 Nov;11(4):529-30. Epub 2011 Oct 25. PubMed PMID: 22087408; PubMed Central PMCID: PMC3206762.
  • 231: Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, Keramati MR, Abdollahzade S, Taba Taba Vakili S. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon. 2011 Jun;11(6):452-8. PubMed PMID: 22087177; PubMed Central PMCID: PMC3212791.
  • 232: Mahboobi N, Behnava B, Alavian SM. IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report. Hepat Mon. 2011 May;11(5):386-8. PubMed PMID: 22087170; PubMed Central PMCID: PMC3212776.
  • 233: Zali MR, Rostami Nejad M, Rostami K, Alavian SM. Liver complications in celiac disease. Hepat Mon. 2011 May;11(5):333-41. PubMed PMID: 22087157; PubMed Central PMCID: PMC3212773.
  • 234: Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B. The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation. Hepat Mon. 2011 Apr;11(4):247-54. PubMed PMID: 22087151; PubMed Central PMCID: PMC3206701.
  • 235: Alavian SM, Mahboobi N, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011 Feb;11(2):99-102. PubMed PMID: 22087125; PubMed Central PMCID: PMC3206671.
  • 236: Alavian SM, Miri SM. Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV. Hepat Mon. 2011 Feb;11(2):67-8. PubMed PMID: 22087120; PubMed Central PMCID: PMC3206673.
  • 237: Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM. Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon. 2011 Jan;11(1):3-6. PubMed PMID: 22087107; PubMed Central PMCID: PMC3206652.
  • 238: Ramezani H, Bozorgi SH, Nooranipour M, Sadri M, Molaverdikhani S, Alavian SM. Successful exclusion of blood-borne viral disease in blood donors. Eur J Intern Med. 2011 Dec;22(6):e71-4. doi: 10.1016/j.ejim.2011.07.002. Epub 2011 Jul 27. PubMed PMID: 22075316.
  • 239: Alavian SM. Confidential unit exclusion and blood safety. Sao Paulo Med J. 2011;129(5):359-60. PubMed PMID: 22069137.
  • 240: Jazayeri SM, Alavian SM. HBeAg negativity is not equal to the presence of pre core mutations in chronic hepatitis B patients. Saudi Med J. 2011 Nov;32(11):1206; author reply 1206-7. PubMed PMID: 22057616.
  • 241: Alavian SM. Hepatitis B vaccination in hemodialysis patients: different points of view for conclusion. J Bras Nefrol. 2011 Jul-Sep;33(3):389-90; author reply 391. PubMed PMID: 22042355.
  • 242: Alavian SM, Aalaei-Andabili SH. The impact of HBV vaccination on Brazilian adolescents requires more attention. Cad Saude Publica. 2011 Oct;27(10):2070. PubMed PMID: 22031212.
  • 243: Alavian SM. Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons. Rev Soc Bras Med Trop. 2011 Oct;44(5):652; author reply 653. PubMed PMID: 22031090.
  • 244: Alavian SM. Commentary on: Treatment of HCV infection in chronic kidney disease. Nefrologia. 2011;31(5):607; author reply 607-8. doi: 10.3265/Nefrologia.pre2011.Jun.10983. PubMed PMID: 21959730.
  • 245: Alavian SM. New globally faces of hepatitis B and C in the world. Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):171-4. PubMed PMID: 24834179; PubMed Central PMCID: PMC4017437.
  • 246: Alavian SM. Hepatitis a in developed country, the result should interpret carefully. Gut Liver. 2011 Sep;5(3):395-6. doi: 10.5009/gnl.2011.5.3.395. Epub 2011 Aug 18. PubMed PMID: 21927674; PubMed Central PMCID: PMC3166686.
  • 247: Alavian SM, Miri SM, Tabatabaei SV, Keshvari M, Behnava B, Elizee PK, Mahboobi N, Lankarani KB. Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients. Gut Liver. 2011 Sep;5(3):348-55. doi: 10.5009/gnl.2011.5.3.348. Epub 2011 Aug 18. PubMed PMID: 21927665; PubMed Central PMCID: PMC3166677.
  • 248: Alavian SM, Jazayeri SM. Other views of occult hepatitis B in Hepatitis C infected patients. Eur J Intern Med. 2011 Oct;22(5):e67-8. doi: 10.1016/j.ejim.2011.05.003. Epub 2011 Jun 1. PubMed PMID: 21925047.
  • 249: Alavian SM. Epidemiology of Hepatitis B virus infection and the main risk factors in Pakistan needs more attention. Saudi J Gastroenterol. 2011 Sep-Oct;17(5):369-70. doi: 10.4103/1319-3767.84505. PubMed PMID: 21912070; PubMed Central PMCID: PMC3178932.
  • 250: Jazayeri SM, Alavian SM. Commentary on emergence of hepatitis B virus S gene mutants in patients experiencing HBsAg seroconversion after peginterferon therapy. Hepatology. 2011 Nov;54(5):1889; author reply 1889-90. doi: 10.1002/hep.24650. PubMed PMID: 21898500.
  • 251: Jazayeri SM, Miri SM, Alavian SM. YMDD motif mutation after lamivudine therapy. Asian J Transfus Sci. 2011 Jul;5(2):178-9. doi: 10.4103/0973-6247.83252. PubMed PMID: 21897603; PubMed Central PMCID: PMC3159254.
  • 252: Alavi-Moghaddam M, Alavian SM, Aalaei-Andabili SH, Eslami-Far A. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients? Vaccine. 2011 Nov 8;29(48):9093-7. doi: 10.1016/j.vaccine.2011.08.094. Epub 2011 Sep 3. PubMed PMID: 21893143.
  • 253: Alavian SM, Aalaei-Andabili SH. Education by a nurse increases the adherence to therapy in chronic hepatitis C patients. Clin Gastroenterol Hepatol. 2012 Feb;10(2):203; author reply 203. doi: 10.1016/j.cgh.2011.08.004. Epub 2011 Aug 11. PubMed PMID: 21839708.
  • 254: Alavian SM, Aalaei-Andabili SH. More risk factors of hepatitis C transmission should be considered in Pakistan. Int J Prev Med. 2011 Jul;2(3):188-9. PubMed PMID: 21811664; PubMed Central PMCID: PMC3143535.
  • 255: Alavian SM, Mahboobi N. Hepatitis B infection in dentistry setting needs more attention. Med Princ Pract. 2011;20(5):491-2. doi: 10.1159/000328427. Epub 2011 Jul 11. PubMed PMID: 21757945.
  • 256: Alavian SM. Hepatitis A. Aust Fam Physician. 2011 Apr;40(4):185. PubMed PMID: 21744525.
  • 257: Alavian SM, Saiedi SY, Alaei SH. Epidemiology of hepatitis C in the Middle East: all available data. Saudi J Kidney Dis Transpl. 2011 Jul;22(4):808-9. PubMed PMID: 21743238.
  • 258: Poustchi H, George J, Esmaili S, Esna-Ashari F, Ardalan G, Sepanlou SG, Alavian SM. Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One. 2011;6(6):e21178. doi: 10.1371/journal.pone.0021178. Epub 2011 Jun 27. PubMed PMID: 21738618; PubMed Central PMCID: PMC3124486.
  • 259: Jazayeri SM, Miri SM, Alavian SM. Hepatitis B genotypes distribution in South Asia and Middle East. Infect Genet Evol. 2011 Aug;11(6):1193-4. doi: 10.1016/j.meegid.2011.04.032. Epub 2011 May 11. PubMed PMID: 21600304.
  • 260: Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, Mohammad Alizadeh AH. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011 Jun;83(6):989-95. doi: 10.1002/jmv.22044. PubMed PMID: 21503911.
  • 261: Miri SM, Alavian SM. Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community. Hepat Mon. 2011 Apr 1;11(4):238-9. PubMed PMID: 22706271; PubMed Central PMCID: PMC3206697.
  • 262: Alavian SM. Occult hepatitis B in high-risk patients needs more attention. J Infect Dev Ctries. 2011 Mar 2;5(2):149-50. PubMed PMID: 21389597.
  • 263: Ramezani H, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, Mazdaki A, Alavian SM. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran. Singapore Med J. 2011 Feb;52(2):107-12. PubMed PMID: 21373737.
  • 264: Amirkhani MA, Alavian SM, Maesoumi H, Aminaie T, Dashti M, Ardalan G, Ziaoddini H, Mirmoghtadaee P, Poursafa P, Kelishadi R. A nationwide survey of prevalence of pediculosis in children and adolescents in iran. Iran Red Crescent Med J. 2011 Mar;13(3):167-70. Epub 2011 Mar 1. PubMed PMID: 22737457; PubMed Central PMCID: PMC3371940.
  • 265: Asli AA, Moghadami M, Zamiri N, Tolide-Ei HR, Heydari ST, Alavian SM, Lankarani KB. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy. 2011 May;100(2-3):297-304. doi: 10.1016/j.healthpol.2010.12.007. Epub 2011 Jan 26. PubMed PMID: 21269722.
  • 266: Zamani F, Fallahian F, Hashemi F, Shamsaei Z, Alavian SM. Immune response to hepatitis B vaccine in health-care workers. Saudi J Kidney Dis Transpl. 2011 Jan;22(1):179-84. PubMed PMID: 21196642.
  • 267: Alavian SM. Intrafamily transmission of HCV need to more discussion. Iran Red Crescent Med J. 2011 Jan;13(1):64. Epub 2011 Jan 1. PubMed PMID: 22946024; PubMed Central PMCID: PMC3407591.
  • 268: Kabir A, Alavian SM. Comment on: Epidemiology of Hepatitis B Virus Infection in Hamadan, West of Iran. J Res Health Sci. 2011 Nov 4;11(2):121-3. PubMed PMID: 22911963.
  • 269: Alavian SM. Elevated prevalence of hepatitis B in Mexican hemodialysis patients. A multicentric survey. Arch Med Res. 2010 Oct;41(7):576; author reply 577. doi: 10.1016/j.arcmed.2010.09.004. PubMed PMID: 21167398.
  • 270: Tabatabaei SV, Alavian SM, Keshvari M, Behnava B, Miri SM, Elizee PK, Zamani F, Kafi-Abad SA, Gharehbaghian A, Hajibeigy B, Lankarani KB. WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy. J Hepatol. 2010 Nov 23. [Epub ahead of print] PubMed PMID: 21145858.
  • 271: Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM. Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev. 2010;11(4):859-62. PubMed PMID: 21133591.
  • 272: Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010 Dec;9(4):191-206. doi: 09.04/ijaai.191206. Review. PubMed PMID: 21131699.
  • 273: Alavian SM, Tabatabaei SV. Effect of oral levamisole on immunological response to hepatitis B vaccine in haemodialysis patients. Aliment Pharmacol Ther. 2011 Jan;33(1):160; author reply 161. doi: 10.1111/j.1365-2036.2010.04488.x. PubMed PMID: 21128985.
  • 274: Alavian SM, Zamiri N, Gooya MM, Tehrani A, Heydari ST, Lankarani KB. Hepatitis B vaccination of adolescents: a report on the national program in Iran. J Public Health Policy. 2010 Dec;31(4):478-93. doi: 10.1057/jphp.2010.35. PubMed PMID: 21119653.
  • 275: Alavian SM. Occult hepatitis B and hemodialysis patients need increased precautions with the interpretation of results. Ther Apher Dial. 2010 Dec;14(6):609-10; author reply 610-1. doi: 10.1111/j.1744-9987.2010.00878.x. Epub 2010 Oct 29. PubMed PMID: 21118374.
  • 276: Lankarani KB, Alavian SM, Haghdoost AA. Family physicians in Iran: success despite challenges. Lancet. 2010 Nov 6;376(9752):1540-1. doi: 10.1016/S0140-6736(10)62029-6. PubMed PMID: 21056761.
  • 277: Sima H, Hekmatdoost A, Ghaziani T, Alavian SM, Mashayekh A, Zali MR. The prevalence of celiac autoantibodies in hepatitis patients. Iran J Allergy Asthma Immunol. 2010 Sep;9(3):157-62. doi: 09.03/ijaai.157162. PubMed PMID: 20952805.
  • 278: Khattab MA, Eslam M, Alavian SM. Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection. Hepat Mon. 2010 Fall;10(4):258-69. Epub 2010 Dec 1. PubMed PMID: 22312391; PubMed Central PMCID: PMC3271318.
  • 279: Alavian SM, Behnava B, Tabatabaei SV. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2010 Nov;66(11):1071-9. doi: 10.1007/s00228-010-0881-7. Epub 2010 Sep 21. Review. PubMed PMID: 20857094.
  • 280: Alavian SM. Re: renal involvement in patients with hepatitis C virus infection. Iran J Kidney Dis. 2010 Oct;4(4):345. PubMed PMID: 20852380.
  • 281: Fallahian F, Alavian SM, Rasoulinejad M. Epidemiology and transmission of hepatitis G virus infection in dialysis patients. Saudi J Kidney Dis Transpl. 2010 Sep;21(5):831-4. Review. PubMed PMID: 20814115.
  • 282: Daryani NE, Daryani NE, Alavian SM, Zare A, Fereshtehnejad SM, Keramati MR, Pashaei MR, Habibollahi P. Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings. World J Gastroenterol. 2010 Sep 7;16(33):4169-75. PubMed PMID: 20806434; PubMed Central PMCID: PMC2932921.
  • 283: Moghaddam ES, Khosravi S, Ghorbani GA, Alavian SM. Hepatitis B core antibody in blood donor in Sistan-Balutuestan province of Iran. Indian J Med Sci. 2010 Sep;64(9):391-5. PubMed PMID: 23006417.
  • 284: Raoufy MR, Vahdani P, Alavian SM, Fekri S, Eftekhari P, Gharibzadeh S. A novel method for diagnosing cirrhosis in patients with chronic hepatitis B: artificial neural network approach. J Med Syst. 2011 Feb;35(1):121-6. doi: 10.1007/s10916-009-9348-8. Epub 2009 Jul 21. PubMed PMID: 20703578.
  • 285: Ghamar Chehreh ME, Tabatabaei SV, Khazanehdari S, Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet. 2011 Feb;283(2):255-60. doi: 10.1007/s00404-010-1588-9. Epub 2010 Jul 21. PubMed PMID: 20652289.
  • 286: Alavian SM, Behnava B, Tabatabaei SV. Erythropoietin adjuvant therapy and sustained virological response in HCV-infected patients. Aliment Pharmacol Ther. 2010 Aug;32(3):509-10. doi: 10.1111/j.1365-2036.2010.04365.x. PubMed PMID: 20636703.
  • 287: Alavian SM, Tabatabaei SV, Keshvari M, Behnava B, Miri SM, Elizee PK, Lankarani KB. Peginterferon alpha-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases. Liver Int. 2010 Sep;30(8):1173-80. doi: 10.1111/j.1478-3231.2010.02296.x. Epub 2010 Jul 8. PubMed PMID: 20629950.
  • 288: Alavian SM, Tabatabaei SV. Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection. Iran J Kidney Dis. 2010 Jul;4(3):181-94. PubMed PMID: 20622305.
  • 289: Fallahian F, Alavian SM, Fallahian V, Zamani F. Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis. Saudi J Kidney Dis Transpl. 2010 Jul;21(4):621-7. Review. PubMed PMID: 20587863.
  • 290: Asadi Noghabi AA, Zandi M, Mehran A, Alavian SM, Dehkordi AH. The effect of education on quality of life in patients under interferon therapy. Hepat Mon. 2010 Summer;10(3):218-22. Epub 2010 Sep 1. PubMed PMID: 22308142; PubMed Central PMCID: PMC3269087.
  • 291: Kashani HH, Vossoughi A, Adibi P, Alavian SM. Amazing results with hydroxyurea therapy in chronic hepatitis B: a preliminary report. Hepat Mon. 2010 Summer;10(3):215-7. Epub 2010 Sep 1. PubMed PMID: 22308141; PubMed Central PMCID: PMC3269086.
  • 292: Kabir A, Tabatabaei SV, Khaleghi S, Agah S, Faghihi Kashani AH, Moghimi M, Habibi Kerahroodi F, Alavian SE, Alavian SM. Knowledge, attitudes and practice of Iranian medical specialists regarding hepatitis B and C. Hepat Mon. 2010 Summer;10(3):176-82. Epub 2010 Sep 1. PubMed PMID: 22308136; PubMed Central PMCID: PMC3269081.
  • 293: Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int. 2010 Jul;14(3):253-62. doi: 10.1111/j.1542-4758.2010.00437.x. Epub 2010 May 17. Review. PubMed PMID: 20491973.
  • 294: Alavian SM, Tabatabaei SV. Immunological response to hepatitis B vaccine in polytransfused thalassemic patients. Pediatr Hematol Oncol. 2010 May;27(4):324-5; author reply 326-7. doi: 10.3109/08880010903530907. PubMed PMID: 20426525.
  • 295: Alavian SM, Tabatabaei SV. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature. Vaccine. 2010 May 14;28(22):3773-7. doi: 10.1016/j.vaccine.2010.03.038. Epub 2010 Apr 4. Review. PubMed PMID: 20371390.
  • 296: Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol. 2010;31(5):398-407. doi: 10.1159/000294505. Epub 2010 Mar 31. Review. PubMed PMID: 20357431.
  • 297: Alavian SM, Behnava B, Tabatabaei SV. The comparative efficacy and safety of peginterferon alpha-2a vs. 2b for the treatment of chronic HCV infection: a meta-analysis. Hepat Mon. 2010 Spring;10(2):121-31. Epub 2010 Jun 1. PubMed PMID: 22312385; PubMed Central PMCID: PMC3270355.
  • 298: Shohrati M, Dermanaki F, Babaei F, Alavian SM. Evaluation of the effects of oral N-acetylcysteine and a placebo in paraclinical and oxidative stress parameters of patients with chronic hepatitis B. Hepat Mon. 2010 Spring;10(2):95-100. Epub 2010 Jun 1. PubMed PMID: 22312380; PubMed Central PMCID: PMC3270363.
  • 299: Alavian SM. Unthought-of problems regarding hepatitis D virus infection. Hepat Mon. 2010 Spring;10(2):77-9. Epub 2010 Jun 1. PubMed PMID: 22312377; PubMed Central PMCID: PMC3270360.
  • 300: Alavian SM. Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors. Saudi J Kidney Dis Transpl. 2010 Mar;21(2):357-8; author reply 358. PubMed PMID: 20228532.
  • 301: Mahboobi N, Agha-Hosseini F, Mahboobi N, Safari S, Lavanchy D, Alavian SM. Hepatitis B virus infection in dentistry: a forgotten topic. J Viral Hepat. 2010 May;17(5):307-16. doi: 10.1111/j.1365-2893.2010.01284.x. Epub 2010 Feb 25. Review. PubMed PMID: 20196802.
  • 302: Alavian SM, Tabatabaei SV. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials. Clin Ther. 2010 Jan;32(1):1-10. doi: 10.1016/j.clinthera.2010.01.005. PubMed PMID: 20171406.
  • 303: Einollahi B, Alavian SM. Hepatitis C virus infection and kidney transplantation: a review for clinicians. Iran J Kidney Dis. 2010 Jan;4(1):1-8. Review. PubMed PMID: 20081297.
  • 304: Alavian SM, Fallahian F, Lankarani KB. Implementing strategies for hepatitis B vaccination. Saudi J Kidney Dis Transpl. 2010 Jan;21(1):10-22. Review. PubMed PMID: 20061687.
  • 305: Einollahi B, Alavian SM, Lessan-Pezeshki M, Simforoosh N, Nourbala MH, Rostami Z, Pourfarziani V, Nemati E, Sharafi M, Nafar M, Pour-Reza Gholi F, Firoozan A. The impact of hepatitis B infection on outcome of kidney transplantation: a long-term study. Int J Organ Transplant Med. 2010;1(2):91-3. PubMed PMID: 25013571; PubMed Central PMCID: PMC4089227.
  • 306: Amirkhani M, Alavian S, Dashti M, Aminaie T, Ardalan G, Ziaoddini H, Mirmoghtadaee P, Poursafa P, Kelishadi R. Nationwide report on the findings of integrated school health screening program in iran. Iran J Public Health. 2010;39(2):13-7. Epub 2010 Jun 30. PubMed PMID: 23113001; PubMed Central PMCID: PMC3481762.
  • 307: Behnava B, Alavian SM. A woman with recent jaundice and pruritus. Hepat Mon. 2010 Winter;10(1):48-52. Epub 2010 Mar 1. PubMed PMID: 22308126; PubMed Central PMCID: PMC3270345.
  • 308: Alavian SM. A Look at the Past History of Hepatitis E in Haiti: Should it be a Warning Sign during the Current Crisis? Hepat Mon. 2010 Winter;10(1):9-11. Epub 2010 Mar 1. PubMed PMID: 22308118; PubMed Central PMCID: PMC3270337.
  • 309: Jazayeri SM, Alavian SM, Carman WF. Hepatitis B virus: origin and evolution. J Viral Hepat. 2010 Apr;17(4):229-35. doi: 10.1111/j.1365-2893.2009.01193.x. Epub 2009 Nov 30. Review. PubMed PMID: 20002567.
  • 310: Alavian SM, Tabatabaei SV. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin. Eur J Gastroenterol Hepatol. 2010 Jan;22(1):123-4. doi: 10.1097/MEG.0b013e32832e0a66. PubMed PMID: 19959942.
  • 311: Azarkeivan A, Hajibeigi B, Alavian SM, Lankarani MM, Assari S. Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia. J Res Med Sci. 2009 Nov;14(6):349-55. PubMed PMID: 21772908; PubMed Central PMCID: PMC3129078.
  • 312: Taheri S, Alavian SM, Einollahi B, Nafar M. Gender bias in Iranian living kidney transplantation program: a national report. Clin Transplant. 2010 Jul-Aug;24(4):528-34. doi: 10.1111/j.1399-0012.2009.01120.x. PubMed PMID: 19843109.
  • 313: Alavian SM. Patient survival after renal transplantation in HCV and HBV infected patients needs more attention than other risk factors. Clin Nephrol. 2009 Oct;72(4):326-7. PubMed PMID: 19825342.
  • 314: Habibollahi P, Safari S, Daryani NE, Alavian SM. Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection. Saudi J Gastroenterol. 2009 Oct-Dec;15(4):220-4. doi: 10.4103/1319-3767.56089. Review. PubMed PMID: 19794265; PubMed Central PMCID: PMC2981836.
  • 315: Sendi H, Mehrab-Mohseni M, Shahraz S, Norder H, Alavian SM, Noorinayer B, Zali MR, Pumpens P, Bonkovsky HL, Magnius LO. CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA. J Clin Virol. 2009 Nov;46(3):259-64. doi: 10.1016/j.jcv.2009.08.002. Epub 2009 Sep 12. PubMed PMID: 19748824; PubMed Central PMCID: PMC2763602.
  • 316: Alavian SM, Tabatabaei SV, Ayyub M. Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease. Saudi Med J. 2009 Aug;30(8):1107-8; author reply 1107-8. PubMed PMID: 19668900.
  • 317: Alavian SM, Tabatabaei SV. Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis. J Viral Hepat. 2010 Apr;17(4):236-44. doi: 10.1111/j.1365-2893.2009.01170.x. Epub 2009 Jul 23. PubMed PMID: 19638104.
  • 318: Khedmat H, Alavian SM, Taheri S. Significance of human leukocyte antigen typing in kidney transplantation: time to revisit old strategies? Iran J Kidney Dis. 2009 Jul;3(3):176-7. PubMed PMID: 19617671.
  • 319: Alavian SM, Tabatabaei SV. Therapy of hepatitis C in thalassemia: the influence of iron on achieving sustained viral response. Ann Hematol. 2010 Feb;89(2):215-6. doi: 10.1007/s00277-009-0785-8. Epub 2009 Jul 10. PubMed PMID: 19590873.
  • 320: Alavian SM, Tabatabaei SV. RE: Serum viral markers in Iranian patients with congenital bleeding disorder. Ann Saudi Med. 2009 Jul-Aug;29(4):322. PubMed PMID: 19584583; PubMed Central PMCID: PMC2841466.
  • 321: Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, Lankarani KB. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. 2009 Oct;49(10):2195-9. doi: 10.1111/j.1537-2995.2009.02252.x. Epub 2009 Jun 15. PubMed PMID: 19538541.
  • 322: Somi MH, Farhang S, Miri SM, Pouri AA, Mjidi G, Alavian SM. The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? Trop Doct. 2009 Jul;39(3):154-6. doi: 10.1258/td.2009.080365. PubMed PMID: 19535751.
  • 323: Khedmat H, Alavian SM, Taheri S. Pregnancy after renal transplantation: prospects and concerns. Ann Transplant. 2009 Apr-Jun;14(2):55-60. Review. PubMed PMID: 19487796.
  • 324: Hajibeigi B, Azarkeyvan A, Alavian SM, Lankarani MM, Assari S. Anxiety and depression affects life and sleep quality in adults with beta-thalassemia. Indian J Hematol Blood Transfus. 2009 Jun;25(2):59-65. doi: 10.1007/s12288-009-0015-5. Epub 2009 Jul 5. PubMed PMID: 23100977; PubMed Central PMCID: PMC3452956.
  • 325: Alavian SM. Re: posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital. Iran J Kidney Dis. 2008 Apr;2(2):110-1. PubMed PMID: 19377221.
  • 326: Hosseini-Moghaddam SM, Mousavi A, Alavian SM. Is {beta}-interferon a promising therapeutic option for the management of hepatitis C? J Antimicrob Chemother. 2009 Jun;63(6):1097-103. doi: 10.1093/jac/dkp092. Epub 2009 Mar 27. Review. PubMed PMID: 19329508.
  • 327: Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat. 2009 Apr;16(4):259-64. doi: 10.1111/j.1365-2893.2009.01069.x. Epub 2009 Feb 12. PubMed PMID: 19222745.
  • 328: Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol. 2009 Feb 14;15(6):641-6. PubMed PMID: 19222088; PubMed Central PMCID: PMC2653433.
  • 329: Nemati E, Alavian SM, Taheri S, Moradi M, Pourfarziani V, Einollahi B. Hepatitis C virus infection among patients on hemodialysis: a report from a single center in Iran. Saudi J Kidney Dis Transpl. 2009 Jan;20(1):147-53. PubMed PMID: 19112238.
  • 330: Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, Jafari AM. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007 Dec 15;10(24):4461-6. PubMed PMID: 19093512.
  • 331: Alavian SM, Izadi M, Zare AA, Lankarani MM, Assari S, Vardi MM. Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists. Spec Care Dentist. 2008 Nov-Dec;28(6):265-70. doi: 10.1111/j.1754-4505.2008.00052.x. PubMed PMID: 19068068.
  • 332: Ghorbani GA, Alavian SM, Ghadimi HR. Long term effects of one or two doses of hepatitis B vaccine in adults after five years. Pak J Biol Sci. 2008 Feb 15;11(4):660-3. PubMed PMID: 18817145.
  • 333: Bahramali G, Sadeghizadeh M, Amini-Bavil-Olyaee S, Alavian SM, Behzad-Behbahani A, Adeli A, Aghasadeghi MR, Amini S, Mahboudi F. Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol. 2008 Sep 21;14(35):5448-53. PubMed PMID: 18803358; PubMed Central PMCID: PMC2744168.
  • 334: Rabbani A, Alavian SM, Motlagh ME, Ashtiani MT, Ardalan G, Salavati A, Rabbani B, Rabbani A, Shams S, Parvaneh N. Vitamin D insufficiency among children and adolescents living in Tehran, Iran. J Trop Pediatr. 2009 Jun;55(3):189-91. doi: 10.1093/tropej/fmn078. Epub 2008 Sep 5. PubMed PMID: 18775944.
  • 335: Hosseini Moghaddam SM, Alavian SM, Rahnavardi M. Therapeutic aspects of hepatitis C in hemodialysis patients. Am J Nephrol. 2009;29(2):123-8. doi: 10.1159/000151633. Epub 2008 Aug 22. PubMed PMID: 18719345.
  • 336: Moghaddam SM, Alavian SM, Kermani NA. Hepatitis C and renal transplantation: a review on historical aspects and current issues. Rev Med Virol. 2008 Nov-Dec;18(6):375-86. doi: 10.1002/rmv.590. Review. PubMed PMID: 18702126.
  • 337: Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008 Jul;12(3):378-82. doi: 10.1111/j.1542-4758.2008.00284.x. PubMed PMID: 18638096.
  • 338: Moghimi M, Marashi SA, Kabir A, Taghipour HR, Faghihi-Kashani AH, Ghoddoosi I, Alavian SM. Knowledge, attitude, and practice of Iranian surgeons about blood-borne diseases. J Surg Res. 2009 Jan;151(1):80-4. doi: 10.1016/j.jss.2007.12.803. Epub 2008 Feb 1. PubMed PMID: 18599085.
  • 339: Sali S, Alavian SM, Hajarizadeh B. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients. Nephrology (Carlton). 2008 Oct;13(5):376-9. doi: 10.1111/j.1440-1797.2008.00952.x. Epub 2008 May 29. PubMed PMID: 18518938.
  • 340: Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009 Feb;29(2):159-63. doi: 10.1111/j.1478-3231.2008.01790.x. Epub 2008 May 19. PubMed PMID: 18492015.
  • 341: Hosseini-Moghaddam SM, Keyvani H, Samadi M, Alavian SM, Mahdavimazdeh M, Daneshvar S, Razzaghi Z. GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus. J Med Virol. 2008 Jul;80(7):1260-3. doi: 10.1002/jmv.21161. PubMed PMID: 18461616.
  • 342: Kabir A, Keshvari M, Kashani AH, Alavian SM. Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs. Hum Vaccin. 2008 Sep-Oct;4(5):379-83. Epub 2008 Sep 2. PubMed PMID: 18398305.
  • 343: Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol. 2008;28(4):628-40. doi: 10.1159/000117573. Epub 2008 Feb 19. Review. PubMed PMID: 18285684.
  • 344: Alavian SM. 'Liver: an alarm for the heart?'. Liver Int. 2008 Feb;28(2):283; author reply 284-5. doi: 10.1111/j.1478-3231.2007.01621.x. PubMed PMID: 18251983.
  • 345: Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007 Dec;16(4):403-6. Review. PubMed PMID: 18193122.
  • 346: Alavian SM, Mansouri S, Abouzari M, Assari S, Bonab MS, Miri SM. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005). Eur J Gastroenterol Hepatol. 2008 Feb;20(2):131-4. doi: 10.1097/MEG.0b013e3282f1cc28. PubMed PMID: 18188034.
  • 347: Alavian SM, Motlagh ME, Ardalan G, Motaghian M, Davarpanah AH, Kelishadi R. Hypertriglyceridemic waist phenotype and associated lifestyle factors in a national population of youths: CASPIAN Study. J Trop Pediatr. 2008 Jun;54(3):169-77. Epub 2007 Dec 21. PubMed PMID: 18156644.
  • 348: Hosseinpoor AR, Naghavi M, Alavian SM, Speybroeck N, Jamshidi H, Vega J. Determinants of seeking needed outpatient care in Iran: results from a national health services utilization survey. Arch Iran Med. 2007 Oct;10(4):439-45. Erratum in: Arch Iran Med. 2008 Jan;11(1):135. PubMed PMID: 17903047.
  • 349: Amini-Bavil-Olyaee S, Hosseini SY, Sabahi F, Alavian SM. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine. Int J Infect Dis. 2008 Jan;12(1):83-7. Epub 2007 Aug 14. PubMed PMID: 17698384.
  • 350: Alidoust L, Zafarghandi M, Agah M, Sendi H, Alavian SM, Zali MR. Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study. Indian J Gastroenterol. 2007 Mar-Apr;26(2):97-9. PubMed PMID: 17558082.
  • 351: Ghaziani T, Alavian SM, Zali MR, Shahraz S, Agah M, Jensen KP, Ansari S, Sendi H, Lambrecht RW, Covault J, Bonkovsky HL. Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection. Hepatol Res. 2007 Mar;37(3):172-8. PubMed PMID: 17362299.
  • 352: Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, Adibi P, Sadri GH, Keramat F, Ardalan A, Arabi M, Gharekhani S, Ataei A, Amraei GR, Hosseinzadeh M, Hatami S, Zali M. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006 Sep;12(5):528-37. PubMed PMID: 17333790.
  • 353: Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007 Feb;37(2):101-3. PubMed PMID: 17300704.
  • 354: Mohammad Alizadeh AH, Fallahian F, Alavian SM, Ranjbar M, Hedayati M, Rahimi F, Khedmat H, Etemadi A, Zali MR, Azizi F. Insulin resistance in chronic hepatitis B and C. Indian J Gastroenterol. 2006 Nov-Dec;25(6):286-9. PubMed PMID: 17264427.
  • 355: Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, Zand V, Azami AA, Hosseini MM, Faridi AR, Davari K, Hajibeigi B. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006 Oct;9(4):319-23. PubMed PMID: 17061602.
  • 356: Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol. 2006 Oct 2;5:4. PubMed PMID: 17014721; PubMed Central PMCID: PMC1599752.
  • 357: Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res. 2006 Dec;36(4):265-71. Epub 2006 Sep 11. PubMed PMID: 16965939.
  • 358: Hosseini SY, Sabahi F, Amini-Bavil-Olyaee S, Alavian SM, Merat S. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains. J Virol Methods. 2006 Nov;137(2):298-303. Epub 2006 Sep 8. PubMed PMID: 16962669.
  • 359: Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sadeghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol. 2006 Aug 28;12(32):5211-3. PubMed PMID: 16937535; PubMed Central PMCID: PMC4088022.
  • 360: Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006 May;78(5):569-73. PubMed PMID: 16555284.
  • 361: Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F, Sabouri E, Tavangar HR, Azizi M, Mahboudi F. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol. 2006 Mar;78(3):358-64. PubMed PMID: 16419114.
  • 362: Hashemi M, Alavian SM, Ghavami S, de Serres FJ, Salehi M, Doroudi T, Fard AH, Mehrabifar H, Milani B, Shahri SJ. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res. 2005 Dec;33(4):292-7. Epub 2005 Nov 2. PubMed PMID: 16260177.
  • 363: Ghavami S, Hashemi M, Kadkhoda K, Alavian SM, Bay GH, Los M. Apoptosis in liver diseases--detection and therapeutic applications. Med Sci Monit. 2005 Nov;11(11):RA337-45. Review. PubMed PMID: 16258409.
  • 364: Huseini HF, Alavian SM, Heshmat R, Heydari MR, Abolmaali K. The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach. Phytomedicine. 2005 Sep;12(9):619-24. PubMed PMID: 16194047.
  • 365: Alavian SM, Akbari H, Ahmadzad-Asl M, Kazem M, Davoudi A, Tavangar H. Concerns regarding dentists' compliance in hepatitis B vaccination and infection control. Am J Infect Control. 2005 Sep;33(7):428-9. PubMed PMID: 16153491.
  • 366: Mohammad Alizadeh AH, Ranjbar M, Ansari S, Alavian SM, Shalmani HM, Hekmat L, Zali MR. Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol. 2005 Aug 21;11(31):4857-60. PubMed PMID: 16097058; PubMed Central PMCID: PMC4398736.
  • 367: Mohammad Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol. 2005 Jul 14;11(26):4085-9. PubMed PMID: 15996035; PubMed Central PMCID: PMC4502106.
  • 368: Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes. 2005 May 18;3:35. PubMed PMID: 15904528; PubMed Central PMCID: PMC1156929.
  • 369: Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. Occult hepatitis B among chronic liver disease patients. Saudi Med J. 2005 Apr;26(4):601-6. PubMed PMID: 15900369.
  • 370: Ghavami S, Hashemi M, Shahriari HA, Bajestani SN, de Serres FJ, Moghaddam EM, Kazemi M, Alavian SM, Taheri M, Blanco I, Fernandez Bustillo E. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran. Clin Biochem. 2005 May;38(5):425-32. PubMed PMID: 15820772.
  • 371: Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour". Sex Transm Infect. 2005 Apr;81(2):185. PubMed PMID: 15800109; PubMed Central PMCID: PMC1764649.
  • 372: Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord. 2004 Nov 19;4(1):4. PubMed PMID: 15555059; PubMed Central PMCID: PMC538272.
  • 373: Adibi P, Ghassemian R, Alavian SM, Ranjbar M, Mohammadalizadeh AH, Nematizadeh F, Mamani M, Rezazadeh M, Keramat F, Ardalan A, Esmaeili A, Zali MR. Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers. Saudi Med J. 2004 Oct;25(10):1414-8. PubMed PMID: 15494813.
  • 374: Alavian SM, Hajarizadeh B. Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs. Gut. 2004 Jul;53(7):1057. PubMed PMID: 15194666; PubMed Central PMCID: PMC1774097.
  • 375: Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton). 2003 Oct;8(5):256-60. PubMed PMID: 15012714.
  • 376: Einollahi B, Hamedanizadeh AK, Alavian SM. Brucellosis arthritis--a rare complication of renal transplantation: a case report. Transplant Proc. 2003 Nov;35(7):2698. PubMed PMID: 14612079.
  • 377: Alavian SM, Hajarizadeh B, Einollahi B. Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients. Transplant Proc. 2003 Nov;35(7):2687-8. PubMed PMID: 14612074.
  • 378: Einollahi B, Hajarizadeh B, Simforoosh N, Lessanpezeshki M, Khatami MR, Nourbala MH, Basiri A, Pourfarziani V, Firoozan A, Nafar M, Poorrezagholi F, Sharifian M, Bakhtiari S, Alavian SM. Patient and graft outcome after living donor renal transplantation in Iran: more than 15-year follow-up. Transplant Proc. 2003 Nov;35(7):2605-6. PubMed PMID: 14612036.
  • 379: Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, Pourfarziani V, Alavian SM. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol. 2003 Jul;18(7):836-40. PubMed PMID: 12795757.
  • 380: Alavian SM, Nematizadeh F. Occult HBV infection in patients with serological markers of past HBV infection. Am J Gastroenterol. 2003 Apr;98(4):937-8. PubMed PMID: 12738484.
  • 381: Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002 Oct;17(10):1092-7. PubMed PMID: 12201870.

Links

You are here: Home About Board of Trustees Professor Seyed-Moayed Alavian

Share on: